TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T59328	Epidermal growth factor receptor	D01PZD	Romiplostim	Approved	5329098	C15H14N2O	238.28	CC1=CC(=C(N1)/C=C\\2/C3=CC=CC=C3NC2=O)C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D06IAR	Adenosine	Approved	60961	C10H13N5O4	267.24	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N	IC50 = 195000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0AZ3C	Imatinib	Approved	5291	C29H31N7O	493.6	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0B0AX	HIF-1alpha	Phase 4	5328127	C20H24N6O3	396.4	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC(=CC(=C3)OC)OC	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D02TUL	PF-06651600	Phase 2	118115473	C15H19N5O	285.34	C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0E3TC	Staurosporine	Phase 2	44259	C28H26N4O3	466.5	C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC	IC50 = 178000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0VF6E	PD173074	Phase 2	1401	C28H41N7O3	523.7	CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0OE4F	Imatinib and nilotinib derivative 1	Patented	4369496	C28H29N7O	479.6	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=CC(=C3)NC4=NC=CC(=N4)C5=CN=CC=C5	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0Y3DN	Flavonoid derivative 4	Patented	5280343	C15H10O7	302.23	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O	IC50 = 190000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0YX2B	PMID28460551-Compound-2	Patented	5329102	C22H27FN4O2	398.5	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C	IC50 = 172100 nM	Poor binder
T59328	Epidermal growth factor receptor	D0F8DL	SB 203580	Terminated	176155	C21H16FN3OS	377.4	CS(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F	IC50 = 96000 nM	Poor binder
T59328	Epidermal growth factor receptor	B01EWY	(4-Ethyl-phenyl)-(6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-4-yl)-amine	Investigative	44313484	C18H20N4	292.4	CCC1=CC=C(C=C1)NC2=NC=NC3=C2C4=C(N3)CCCC4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B02NXC	N-Phenyl-4,5-dianilinophthalimide	Investigative	10046873	C26H19N3O2	405.4	C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)N(C3=O)C4=CC=CC=C4)NC5=CC=CC=C5	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B02VBN	(2R)-N-Benzyl-3-[2-[[3-[(2S)-3-(benzylamino)-3-oxo-2-[(2,2,2-trifluoroacetyl)amino]propyl]-1H-indol-2-yl]selanyl]-1H-indol-3-yl]-2-[(2,2,2-trifluoroacetyl)amino]propanamide	Investigative	44355931	C40H34F6N6O4Se	855.7	C1=CC=C(C=C1)CNC(=O)[C@@H](CC2=C(NC3=CC=CC=C32)[Se]C4=C(C5=CC=CC=C5N4)C[C@@H](C(=O)NCC6=CC=CC=C6)NC(=O)C(F)(F)F)NC(=O)C(F)(F)F	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B03LKR	2-(1H-Benzimidazol-2-ylmethyl)-5-(2,3-dimethoxyphenyl)-1,3,4-oxadiazole	Investigative	137633149	C18H16N4O3	336.3	COC1=CC=CC(=C1OC)C2=NN=C(O2)CC3=NC4=CC=CC=C4N3	IC50 = 60953.69 nM	Poor binder
T59328	Epidermal growth factor receptor	B05ONQ	6-(4-Amino-1-cyclopentyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-4H-chromen-4-one	Investigative	24905230	C19H17N5O2	347.4	C1CCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC5=C(C=C4)OC=CC5=O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B07JVE	3-Substituted indolin-2-one 11c	Investigative	5329140	C17H17N3O5S	375.4	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=C(C=CC(=C3)S(=O)(=O)N)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B08KOW	(E)-2-Cyano-N-[3-[4-[3-[[(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]propyl]piperazin-1-yl]propyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide	Investigative	10555151	C30H34N6O6	574.6	C1N(CCN(C1)CCCNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N)CCCNC(=O)/C(=C/C3=CC(=C(C=C3)O)O)/C#N	IC50 ~ 167000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0A4BO	3-Substituted indolin-2-one 16i	Investigative	5329153	C25H24N2O4	416.5	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=C(C=C3)C4=CC=C(C=C4)OC)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0A5JQ	Ethyl 4-[[6-(2,6-dichlorophenyl)-8-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]benzoate	Investigative	5327902	C23H18Cl2N4O3	469.3	CCOC(=O)C1=CC=C(C=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0GSK9	(4-(1-Carboxyethen-2-yl)benzylidene)malononitrile	Investigative	5328783	C13H8N2O2	224.21	C1=CC(=CC=C1/C=C/C(=O)O)C=C(C#N)C#N	Ki = 150000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0HTY1	Dithiobis(1H-indole-3-alkanoic acid) deriv. 36	Investigative	5328567	C26H28N2O4S2	496.6	COC(=O)CCCC1=C(NC2=CC=CC=C21)SSC3=C(C4=CC=CC=C4N3)CCCC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0IQ9N	3-[(Z)-(4-Bromo-2-thienyl)methylidene]-1H-indol-2-one	Investigative	6036100	C13H8BrNOS	306.18	C1=CC=C2C(=C1)/C(=C/C3=CC(=CS3)Br)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0JGR8	Dithiobis(1H-indole-3-alkanoic acid) deriv. 24	Investigative	5328555	C24H24N2O4S	436.5	CN1C2=CC=CC=C2C(=C1SC3=C(C4=CC=CC=C4N3C)CC(=O)OC)CC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0JVZ6	Dimeric Tyrphostin 11	Investigative	5329264	C26H24N6O10	580.5	COC1=CC(=CC(=C1O)[N+](=O)[O-])/C=C(/C(=O)NCCCCNC(=O)/C(=C/C2=CC(=C(C(=C2)OC)O)[N+](=O)[O-])/C#N)\\C#N	IC50 ~ 80000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0KZ4H	N,N'-(Butane-1,4-diyl)bis[(E)-2-cyano-3-(3-bromo-4-hydroxy-5-methoxyphenyl)acrylamide]	Investigative	11802348	C26H24Br2N4O6	648.3	COC1=C(C(=CC(=C1)/C=C(/C(=O)NCCCCNC(=O)/C(=C/C2=CC(=C(C(=C2)Br)O)OC)/C#N)\\C#N)Br)O	IC50 = 102000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0MD1V	3-[3-(1H-Benzoimidazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide	Investigative	44345644	C19H16N4O3S	380.4	COC1=CC(=CC(=C1O)CSC2=NC3=CC=CC=C3N2)/C=C(\\C#N)/C(=O)N	IC50 = 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0NTO4	(6,7,8,9-Tetrahydro-5H-pyrimido[4,5-b]indol-4-yl)-m-tolyl-amine	Investigative	10660240	C17H18N4	278.35	CC1=CC(=CC=C1)NC2=NC=NC3=C2C4=C(N3)CCCC4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0R3LI	1-Methyl-2-methylsulfanyl-N-phenylindole-3-carboxamide	Investigative	5328622	C17H16N2OS	296.4	CN1C2=CC=CC=C2C(=C1SC)C(=O)NC3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0SHG1	(Z)-1-Methyl-3-(4-dimethylaminobenzylidene)indoline-2-one	Investigative	5293755	C18H18N2O	278.3	CN1C2=CC=CC=C2/C(=C/C3=CC=C(C=C3)N(C)C)/C1=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0TFR3	4'-Tert-Butyl-2'-(methoxymethoxy)-1,1'-biphenyl-4-carboxylic acid 2,4,4-trimethylpentyl ester	Investigative	10502559	C27H38O4	426.6	CC(CC(C)(C)C)COC(=O)C1=CC=C(C=C1)C2=C(C=C(C=C2)C(C)(C)C)OCOC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0TUB2	Methyl-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-m-tolyl-amine	Investigative	44355673	C13H13N5	239.28	CC1=CC(=CC=C1)N(C)C2=NC=NC3=C2C=NN3	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0WDV6	4-[[4-Amino-6-cyano-2-(2-hydroxyethylamino)pyrido[2,3-d]pyrimidin-7-yl]amino]benzenesulfonamide	Investigative	57397293	C16H16N8O3S	400.4	C1=CC(=CC=C1NC2=NC3=NC(=NC(=C3C=C2C#N)N)NCCO)S(=O)(=O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0WLH8	N-(7-Methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide	Investigative	58056356	C17H12N4O2S	336.4	COC1=C(C=C2C=CC=NC2=C1)NC(=O)C3=CSC4=CN=CN=C43	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B0YN7B	3-[[2-(4-Morpholin-4-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide	Investigative	134131331	C20H22N6O3S	426.5	C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)NC4=CC(=CC=C4)S(=O)(=O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B10UOE	N-(4-Cyanophenyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxamide	Investigative	10905857	C22H22N6O3	418.4	COC1=C(C=C2C(=C1)C(=NC=N2)N3CCN(CC3)C(=O)NC4=CC=C(C=C4)C#N)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B13AZB	1 H-Indole-3-alkanamide deriv. 10q	Investigative	5328585	C40H34F6N6O4S2	840.9	C1=CC=C(C=C1)CNC(=O)C(CC2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)CC(C(=O)NCC6=CC=CC=C6)NC(=O)C(F)(F)F)NC(=O)C(F)(F)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B15ODW	Indolin-2-one deriv. 4i	Investigative	5329162	C24H22N2O2	370.4	COC1=CC=C(C=C1)C2=CC3=C(C=C2)/C(=C/C4=CC5=C(N4)CCCC5)/C(=O)N3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B15WHX	N-(3-Chloro-2-fluorophenyl)-8,9-dimethoxy-2-methyl-5,6-dihydropyrimido[4,5-b][1,4]benzoxazepin-4-amine	Investigative	44416596	C20H18ClFN4O3	416.8	CC1=NC(=C2C(=N1)OC3=CC(=C(C=C3CN2)OC)OC)NC4=C(C(=CC=C4)Cl)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B19HWO	N-[1-(2-Chloro-6-fluorobenzyl)-1H-pyrazol-3-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide	Investigative	3677514	C16H15ClFN5O	347.77	CC1=NN(C=C1C(=O)NC2=NN(C=C2)CC3=C(C=CC=C3Cl)F)C	IC50 = 72400 nM	Poor binder
T59328	Epidermal growth factor receptor	B1A0HJ	N-Methyl-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;hydrochloride	Investigative	45265103	C12H12ClN5	261.709	CN(C1=CC=CC=C1)C2=NC=NC3=C2C=NN3.Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1A2ZI	N-[5-Chloro-4-(3-methoxyanilino)-9H-pyrimido[4,5-b]indol-2-yl]-2,2-dimethylpropanamide	Investigative	71583635	C22H22ClN5O2	423.9	CC(C)(C)C(=O)NC1=NC2=C(C3=C(N2)C=CC=C3Cl)C(=N1)NC4=CC(=CC=C4)OC	IC50 = 130500 nM	Poor binder
T59328	Epidermal growth factor receptor	B1CD9Y	Dithiobis(1H-indole-3-carboxamide) deriv. 10p	Investigative	5328607	C32H24Cl2N4O2S2	631.6	CN1C2=C(C=CC(=C2)Cl)C(=C1SSC3=C(C4=C(N3C)C=C(C=C4)Cl)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1GV3S	4-Chloro-N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-1-(4-fluorophenyl)-2-oxoquinoline-3-carboxamide	Investigative	127029809	C40H36ClF2N5O5	740.2	CN1CCN(CC1)CCCOC2=CC3=NC=CC(=C3C=C2OC)OC4=C(C=C(C=C4)NC(=O)C5=C(C6=CC=CC=C6N(C5=O)C7=CC=C(C=C7)F)Cl)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1HI3Y	5-(3,6-Dimethoxy-cyclohexa-1,5-dienylmethoxy)-2-hydroxy-benzoic acid methyl ester	Investigative	44353341	C17H20O6	320.3	COC1CC=C(C(=C1)COC2=CC(=C(C=C2)O)C(=O)OC)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1IR3H	4-[4-(5-Bromo-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-phenyl]-piperazine-1-carbaldehyde	Investigative	44321734	C20H18BrN3O2	412.3	C1CN(CCN1C=O)C2=CC=C(C=C2)/C=C\\3/C4=C(C=CC(=C4)Br)NC3=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1L0KP	4-[(4-Amino-6-cyano-5-methylpyrido[2,3-d]pyrimidin-7-yl)amino]benzenesulfonamide	Investigative	57390220	C15H13N7O2S	355.4	CC1=C(C(=NC2=NC=NC(=C12)N)NC3=CC=C(C=C3)S(=O)(=O)N)C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1L4PH	3-(3-Ethoxy-4-methoxyphenyl)-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-4-amine	Investigative	52945630	C17H21N5O2	327.4	CCOC1=C(C=CC(=C1)C2=NN(C3=NC=NC(=C23)N)C(C)C)OC	IC50 = 54200 nM	Poor binder
T59328	Epidermal growth factor receptor	B1M2TH	N4-(3-Bromophenyl)-6-(3,4,5-trimethoxybenzyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	3008965	C22H22BrN5O3	484.3	COC1=CC(=CC(=C1OC)OC)CC2=CC3=C(N2)N=C(N=C3NC4=CC(=CC=C4)Br)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1MX8Q	(3-Nitro-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine	Investigative	9860872	C15H11N5O2	293.28	C1=CC(=CC(=C1)[N+](=O)[O-])NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1NDL0	N-(3-Bromo-4-methylphenyl)-8,9-dimethoxy-2-methyl-5,6-dihydropyrimido[4,5-b][1,4]benzothiazepin-4-amine	Investigative	11705545	C21H21BrN4O2S	473.4	CC1=C(C=C(C=C1)NC2=C3C(=NC(=N2)C)SC4=CC(=C(C=C4CN3)OC)OC)Br	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1TDH3	2-[5-[(2,5-Dihydroxyphenyl)methylideneamino]-2-hydroxyphenyl]acetic acid	Investigative	135407149	C15H13NO5	287.27	C1=CC(=C(C=C1N=CC2=C(C=CC(=C2)O)O)CC(=O)O)O	IC50 = 60000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1U4JF	2-(1H-Benzimidazol-2-ylmethyl)-5-(4-fluorophenyl)-1,3,4-oxadiazole	Investigative	137643535	C16H11FN4O	294.28	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)C4=CC=C(C=C4)F	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1U8YE	6-(2,6-Dichlorophenyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one	Investigative	44294903	C14H9Cl2N3O	306.1	CN1C2=NC=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1UK4E	N-[4-[4-(Diaminomethylideneamino)sulfonylanilino]quinazolin-6-yl]prop-2-enamide	Investigative	76311275	C18H17N7O3S	411.4	C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC=C(C=C3)S(=O)(=O)N=C(N)N	IC50 = 53300 nM	Poor binder
T59328	Epidermal growth factor receptor	B1V3AD	4-N-(4-Nitrophenyl)pyrido[4,3-d]pyrimidine-4,7-diamine	Investigative	5328054	C13H10N6O2	282.26	C1=CC(=CC=C1NC2=NC=NC3=CC(=NC=C32)N)[N+](=O)[O-]	IC50 = 65000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1Y3LJ	1H-Indole-3-acetic acid, 2,3-dihydro-2-thioxo-, methyl ester	Investigative	5328537	C11H11NO2S	221.28	COC(=O)CC1C2=CC=CC=C2NC1=S	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1YFT8	9-Methyl-9H-[1,2,4]triazolo[4,3-a]benzimidazole-3-thiol	Investigative	703960	C9H8N4S	204.25	CN1C2=CC=CC=C2N3C1=NNC3=S	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B1ZV3T	1-Isopropyl-3-(isoquinolin-7-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905217	C17H16N6	304.3	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)C=CN=C4)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B23TPU	2-Methoxy-5-[(2,5-dihydroxybenzylidene)amino]benzoic acid methyl ester	Investigative	135503606	C16H15NO5	301.29	COC1=C(C=C(C=C1)N=CC2=C(C=CC(=C2)O)O)C(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B25PQJ	Chembl4246256	Investigative	145982613	C14H12N4OS	284.34	C1CC2=C(C1)SC3=NN=NC(=C23)NC4=CC(=CC=C4)O	IC50 = 52110 nM	Poor binder
T59328	Epidermal growth factor receptor	B25WIS	2-[3-Methyl-4-hydroxy-5-methoxybenzylidene]propanedinitrile	Investigative	44345337	C12H10N2O2	214.22	CC1=CC(=CC(=C1O)OC)C=C(C#N)C#N	IC50 = 87000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2AJI1	4',6-Diamino-5-hydroxyflavone	Investigative	10445729	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=CC(=C3O)N)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2BMA6	1-Isopropyl-3-(pyrido[3,2-b]pyrazin-7-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905225	C15H14N8	306.33	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=NC=CN=C4N=C3)N	IC50 = 70000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2CKX3	7,8-Dimethoxy-3-methyl-5,10-dihydro-3H-pyrimido[4,5-b]quinolin-4-one	Investigative	15411595	C14H15N3O3	273.29	CN1C=NC2=C(C1=O)CC3=CC(=C(C=C3N2)OC)OC	IC50 = 160000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2DG3N	2-(2,7a-Dihydro-1H-indol-3-ylmethyl)-5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazole	Investigative	137642950	C19H17N5O	331.4	C1C(=C2C=CC=CC2N1)CC3=NN=C(O3)CC4=NC5=CC=CC=C5N4	IC50 = 86200 nM	Poor binder
T59328	Epidermal growth factor receptor	B2E7VS	7,8-Dimethoxy-5,10-dihydro-1H-pyrimido[4,5-b]quinolin-4-one	Investigative	135523696	C13H13N3O3	259.26	COC1=C(C=C2C(=C1)CC3=C(N2)N=CNC3=O)OC	IC50 = 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2EJ7V	4,5-Bis(phenylthio)phthalimide	Investigative	10248155	C20H13NO2S2	363.5	C1=CC=C(C=C1)SC2=C(C=C3C(=C2)C(=O)NC3=O)SC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2EZC1	4-(6,7-Dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)-1-piperazinecarboxamide	Investigative	9911005	C21H22N6O5	438.4	COC1=C(C=C2C(=C1)C(=NC=N2)N3CCN(CC3)C(=O)NC4=CC=C(C=C4)[N+](=O)[O-])OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2F6BW	2-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[b]thiophene-5-carbaldehyde	Investigative	24905163	C17H15N5OS	337.4	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(S3)C=CC(=C4)C=O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2FKA3	N-[1-(4-Hydroxycyclohexyl)-4-methylbenzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	134140222	C22H22F3N3O2	417.4	CC1=C2C(=CC=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4CCC(CC4)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2FY6D	1,3-Dimethyl-6-{[3-(trifluoromethyl)benzyl]amino}-2,4(1H,3H)-pyrimidinedione	Investigative	16069809	C14H14F3N3O2	313.27	CN1C(=CC(=O)N(C1=O)C)NCC2=CC(=CC=C2)C(F)(F)F	IC50 = 83900 nM	Poor binder
T59328	Epidermal growth factor receptor	B2IM8K	(E)-2-Cyano-N-[[4-[(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoyl]piperazin-1-yl]methyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide	Investigative	5468831	C25H23N5O6	489.5	C1CN(CCN1CNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N)C(=O)/C(=C/C3=CC(=C(C=C3)O)O)/C#N	IC50 ~ 83000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2J5GS	2-(4-Hydroxyphenyl)benzothiazol-6-ol	Investigative	135518082	C13H9NO2S	243.28	C1=CC(=CC=C1C2=NC3=C(S2)C=C(C=C3)O)O	IC50 = 130000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2JVQ3	4-((2s)-2-Methoxymethylpyrrolidin-1-yl)but-2-ynoic acid[4-(3-bromophenylamino)-3-cyanoquinolin-6-yl]amide	Investigative	11071370	C26H24BrN5O2	518.4	COC[C@@H]1CCCN1CC#CC(=O)NC2=CC3=C(C(=CN=C3C=C2)C#N)NC4=CC(=CC=C4)Br	IC50 = 150003.02 nM	Poor binder
T59328	Epidermal growth factor receptor	B2JVZ9	Tert-butyl N-[(2R)-1-[[4-(3-bromoanilino)quinazolin-6-yl]amino]-1-oxopropan-2-yl]carbamate	Investigative	137648629	C22H24BrN5O3	486.4	C[C@H](C(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2KA5C	3-(3-Chlorophenyl)-5,7-dimethoxychromen-4-one	Investigative	689033	C17H13ClO4	316.7	COC1=CC2=C(C(=C1)OC)C(=O)C(=CO2)C3=CC(=CC=C3)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2KJ3F	1-[(E)-(2,4-Difluorophenyl)methylideneamino]-3-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperidin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]urea	Investigative	71679855	C33H34F3N5O4	621.6	CC1CCN(CC1)CCCOC2=CC3=NC=CC(=C3C=C2OC)OC4=C(C=C(C=C4)NC(=O)N/N=C/C5=C(C=C(C=C5)F)F)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2NIL7	Di(1,3-dimethyl-1H-2-indolyl) disulfide	Investigative	12484326	C20H20N2S2	352.5	CC1=C(N(C2=CC=CC=C12)C)SSC3=C(C4=CC=CC=C4N3C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2OZS5	N4-(3-Bromophenyl)-6-(naphthalen-1-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	3008950	C23H18BrN5	444.3	C1=CC=C2C(=C1)C=CC=C2CC3=CC4=C(N3)N=C(N=C4NC5=CC(=CC=C5)Br)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B2UR5E	2-Chloro-6,7-dimethoxy-N-(4-(methylsulfonyl)phenyl)quinazolin-4-amine	Investigative	76310006	C17H16ClN3O4S	393.8	COC1=C(C=C2C(=C1)C(=NC(=N2)Cl)NC3=CC=C(C=C3)S(=O)(=O)C)OC	IC50 = 61500 nM	Poor binder
T59328	Epidermal growth factor receptor	B2VAI5	3-Substituted indolin-2-one 16h	Investigative	5329152	C25H24N2O4	416.5	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=C(C=C3)C4=CC=CC=C4OC)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B30LTG	(E)-2-Cyano-N-[10-[[(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]decyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide	Investigative	5329261	C30H34N4O6	546.6	C1=CC(=C(C=C1/C=C(/C(=O)NCCCCCCCCCCNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N)\\C#N)O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B32KNE	N-(3-Bromophenyl)-4-hydroxy-2-oxo-1,2-dihydro-3-quinolinecarboxamide	Investigative	54678831	C16H11BrN2O3	359.17	C1=CC=C2C(=C1)C(=C(C(=O)N2)C(=O)NC3=CC(=CC=C3)Br)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B37AVZ	N-[5-Chloro-4-(4-chloroanilino)-9H-pyrimido[4,5-b]indol-2-yl]-2,2-dimethylpropanamide	Investigative	71583532	C21H19Cl2N5O	428.3	CC(C)(C)C(=O)NC1=NC2=C(C3=C(N2)C=CC=C3Cl)C(=N1)NC4=CC=C(C=C4)Cl	IC50 = 58700 nM	Poor binder
T59328	Epidermal growth factor receptor	B39BMJ	5-(4-Amino-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenol	Investigative	24905291	C13H13N5O2	271.27	CN1C2=NC=NC(=C2C(=N1)C3=CC(=C(C=C3)OC)O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3A9GH	(3r)-1-{2-[4-(4-Acetylphenyl)piperazin-1-Yl]-2-Oxoethyl}-N-(3-Chloro-4-Hydroxyphenyl)pyrrolidine-3-Carboxamide	Investigative	58985201	C25H29ClN4O4	485	CC(=O)C1=CC=C(C=C1)N2CCN(CC2)C(=O)CN3CC[C@H](C3)C(=O)NC4=CC(=C(C=C4)O)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3D4VI	6-[(2,4-Dichlorophenyl)methyl]-4-N-(3-fluorophenyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	46886971	C19H14Cl2FN5	402.2	C1=CC(=CC(=C1)F)NC2=NC(=NC3=C2C=C(N3)CC4=C(C=C(C=C4)Cl)Cl)N	IC50 = 161600 nM	Poor binder
T59328	Epidermal growth factor receptor	B3EA5S	4-[5-(2-Carbamoyl-2-cyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-butyric acid	Investigative	44345334	C16H18N2O5S	350.4	COC1=CC(=CC(=C1O)CSCCCC(=O)O)/C=C(\\C#N)/C(=O)N	IC50 = 60000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3EI8S	2-(1H-Benzimidazol-2-ylmethyl)-5-(furan-2-yl)-1,3,4-oxadiazole	Investigative	137636403	C14H10N4O2	266.25	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)C4=CC=CO4	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3EY8H	6-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)quinolin-4-amine	Investigative	24905233	C17H17N7	319.4	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=CN=C4C=C3)N)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3JB9G	5-[(1E)-2-(5,6-Dibromo-2-hydroxy-3-methoxyphenyl)-1-azavinyl]-3-hydrobenzimida zol-2-one	Investigative	4600415	C15H11Br2N3O3	441.07	COC1=CC(=C(C(=C1O)C=NC2=CC3=C(C=C2)NC(=O)N3)Br)Br	IC50 = 88670 nM	Poor binder
T59328	Epidermal growth factor receptor	B3K2WP	N-[3-[(4-Pyridin-3-ylpyrimidin-2-yl)amino]phenyl]hexanamide	Investigative	11233762	C21H23N5O	361.4	CCCCCC(=O)NC1=CC=CC(=C1)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3K5CY	(E)-3-(3,4-Dihydroxyphenyl)-2-(4-phenylpiperazine-1-carbonyl)prop-2-enenitrile	Investigative	5328780	C20H19N3O3	349.4	C1CN(CCN1C2=CC=CC=C2)C(=O)/C(=C/C3=CC(=C(C=C3)O)O)/C#N	IC50 = 55000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3M5SA	beta-Carbamoyl-beta-cyano-3,5-di-tert-butyl-4-hydroxystyrene	Investigative	5328802	C18H24N2O2	300.4	CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)/C=C(\\C#N)/C(=O)N	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3M6CT	5-(3,6-Dimethoxy-cyclohexa-1,5-dienylmethoxy)-2-hydroxy-benzoic acid	Investigative	44353452	C16H18O6	306.31	COC1CC=C(C(=C1)COC2=CC(=C(C=C2)O)C(=O)O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3M7WB	4,5-Bis[phenyl(methyl)amino]phthalimide	Investigative	10360971	C22H19N3O2	357.4	CN(C1=CC=CC=C1)C2=C(C=C3C(=C2)C(=O)NC3=O)N(C)C4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3QU6L	(E)-2-Cyano-3-[3-[(5-ethoxy-1,3-benzothiazol-2-yl)sulfanylmethyl]-4-hydroxy-5-methoxyphenyl]prop-2-enamide	Investigative	44361915	C21H19N3O4S2	441.5	CCOC1=CC2=C(C=C1)SC(=N2)SCC3=C(C(=CC(=C3)/C=C(\\C#N)/C(=O)N)OC)O	IC50 = 165958.69 nM	Poor binder
T59328	Epidermal growth factor receptor	B3S4UO	Malononitrile, 5-bromovanillylidene-	Investigative	57591	C11H7BrN2O2	279.09	COC1=C(C(=CC(=C1)C=C(C#N)C#N)Br)O	Ki = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3VB8R	3-Substituted indolin-2-one 9d	Investigative	5329137	C25H24N2O4	416.5	CCOC1=CC=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=C(C(=CN4)C)CCC(=O)O)/C(=O)N3	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B3YHZ7	Dithiobis(1H-indole-3-carboxamide) deriv. 10f	Investigative	5328597	C32H24F2N4O2S2	598.7	CN1C2=C(C=C(C=C2)F)C(=C1SSC3=C(C4=C(N3C)C=CC(=C4)F)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B40NLY	4-Methyl-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10110378	C23H19N5O	381.4	CC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B40USL	7-Phenyl-10-sulfanyl-6,12-dihydrobenzo[h][1,2,4]triazolo[4',3':1,2]pyrimido[4,5-b]quinolin-8(5H)-one	Investigative	15942947	C22H15N5OS	397.5	C1CC2=C(C3=C(N=C2C4=CC=CC=C41)N=C5NNC(=S)N5C3=O)C6=CC=CC=C6	IC50 = 85600 nM	Poor binder
T59328	Epidermal growth factor receptor	B40VFE	N-Benzyl-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamide	Investigative	11729539	C22H25N5O2S	423.5	COC1=C(C=C2C(=C1)C(=NC=N2)N3CCN(CC3)C(=S)NCC4=CC=CC=C4)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B43WPI	3-[(E)-2-(4-Chlorophenyl)ethenyl]-N-[(2R)-2,3-dihydroxypropyl]-4-methoxybenzamide	Investigative	57325478	C19H20ClNO4	361.8	COC1=C(C=C(C=C1)C(=O)NC[C@H](CO)O)/C=C/C2=CC=C(C=C2)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B45EMH	2-(3,4-Dihydroxybenzylidene)benzofuran-3(2H)-one	Investigative	21100709	C15H10O4	254.24	C1=CC=C2C(=C1)C(=O)/C(=C\\C3=CC(=C(C=C3)O)O)/O2	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B45GIE	1-Butyl-1-(2-hydroxy-5-methylbenzyl)-3-phenylurea	Investigative	46229461	C19H24N2O2	312.4	CCCCN(CC1=CC=CC(=C1O)C)C(=O)NC2=CC=CC=C2	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B45WCF	Dithiobis(1H-indole-3-carboxamide) deriv. 10s	Investigative	5328610	C36H30N4O6S2	678.8	CC(=O)OC1=CC2=C(C=C1)C(=C(N2C)SSC3=C(C4=C(N3C)C=C(C=C4)OC(=O)C)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B46ABW	5,21-Dihydroxy-13-(methylamino)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione	Investigative	44273526	C27H24N4O9	548.5	CNN1C(=O)C2=C3C4=C(C(=CC=C4)O)NC3=C5C(=C2C1=O)C6=C(N5C7C(C(C(C(O7)CO)O)O)O)C(=CC=C6)O	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B49CPL	Methyl 3-(1-methyl-2-sulfanylidene-3H-indol-3-yl)propanoate	Investigative	5328542	C13H15NO2S	249.33	CN1C2=CC=CC=C2C(C1=S)CCC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B49IBX	N-[2-(2-Methoxyanilino)-4-pyrimidinyl]-N-(2-methoxyphenyl)amine	Investigative	16004616	C18H18N4O2	322.4	COC1=CC=CC=C1NC2=NC(=NC=C2)NC3=CC=CC=C3OC	IC50 = 90400 nM	Poor binder
T59328	Epidermal growth factor receptor	B49VLE	3-(4-(Dimethylamino)benzylidene)-1,3-dihydro-2H-indol-2-one	Investigative	6450842	C17H16N2O	264.32	CN(C)C1=CC=C(C=C1)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B49YWQ	Indolin-2-one deriv. 4f	Investigative	5329159	C23H20N2O	340.4	C1CCC2=C(C1)C=C(N2)/C=C\\3/C4=C(C=C(C=C4)C5=CC=CC=C5)NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4A5CW	[4-[(E)-2-Nitroethenyl]phenyl] 4-[[(2S)-1-[[(2S)-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylamino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]benzenesulfonate	Investigative	14862550	C28H35N5O10S	633.7	C[C@@H](C(=O)N[C@@H](C)C(=O)NCCNC(=O)OC(C)(C)C)NC(=O)C1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)/C=C/[N+](=O)[O-]	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4AZ3J	N-(3-Bromophenyl)phthalazin-1-amine	Investigative	5328021	C14H10BrN3	300.15	C1=CC=C2C(=C1)C=NN=C2NC3=CC(=CC=C3)Br	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4CBY5	2-Hydroxy-5-[(2,5-dihydroxybenzylidene)amino]benzoic acid ethyl ester	Investigative	135400972	C16H15NO5	301.29	CCOC(=O)C1=C(C=CC(=C1)N=CC2=C(C=CC(=C2)O)O)O	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4D2QI	N-[5-Methyl-1-[3-(prop-2-enoylamino)phenyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72699656	C25H19F3N4O2	464.4	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4=CC=CC(=C4)NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4FV1S	4,5-Bis[4-cyanoanilino]phthalimide	Investigative	10407341	C22H13N5O2	379.4	C1=CC(=CC=C1C#N)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4FWG6	3-(2-Nitroethyl)-2-[[3-(2-nitroethyl)-1H-indol-2-yl]disulfanyl]-1H-indole	Investigative	5328572	C20H18N4O4S2	442.5	C1=CC=C2C(=C1)C(=C(N2)SSC3=C(C4=CC=CC=C4N3)CC[N+](=O)[O-])CC[N+](=O)[O-]	IC50 = 89000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4GA2R	3-(3,4-Dichlorophenyl)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-phenyl-3,4-dihydropyrazole	Investigative	127052640	C23H18Cl2N2O2	425.3	C1COC2=C(O1)C=CC(=C2)C3=NN(C(C3)C4=CC(=C(C=C4)Cl)Cl)C5=CC=CC=C5	IC50 = 192000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4H9YM	2-[4-Hydroxy-3-methoxy-5-(toluene-4-sulfonylmethyl)-benzylidene]-malononitrile	Investigative	44345342	C19H16N2O4S	368.4	CC1=CC=C(C=C1)S(=O)(=O)CC2=C(C(=CC(=C2)C=C(C#N)C#N)OC)O	IC50 = 85000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4HX3I	1-Isopropyl-3-(pyrimidin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905171	C12H13N7	255.28	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CN=CN=C3)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4I1TG	N-Tert-butyl-3-[[5-cyano-2-[3-methyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide	Investigative	134130282	C27H34N8O2S	534.7	CC1=C(C=CC(=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)S(=O)(=O)NC(C)(C)C)C#N)N4CCN(CC4)C	IC50 ~ 150000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4MH6G	3N-(3-Pyridyl)-1-methyl-2-[1-methyl-3-(3-pyridylcarbamoyl)-1H-2-indolyldisulfanyl]-1H-3-indolecarboxamide	Investigative	10437879	C30H24N6O2S2	564.7	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CN=CC=C5)C(=O)NC6=CN=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4Q5VD	Methyl 4-{1-methyl-2-[1-methyl-3-(4-methyloxycarbonylphenylcarbamoyl)-1H-2-indolyldisulfanyl]-1H-3-indolylcarboxamido}benzoate H2O	Investigative	10327197	C36H30N4O6S2	678.8	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CC=C(C=C5)C(=O)OC)C(=O)NC6=CC=C(C=C6)C(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4RF3H	(Z)-3-(4-Hydroxyphenyl)-2-pyridin-2-ylprop-2-enenitrile	Investigative	135410197	C14H10N2O	222.24	C1=CC=NC(=C1)/C(=C/C2=CC=C(C=C2)O)/C#N	IC50 = 71700 nM	Poor binder
T59328	Epidermal growth factor receptor	B4U7AY	3-[1-(3-Tert-Butyl-4-methoxy-phenyl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one	Investigative	9995374	C20H21NO2	307.4	CC(C)(C)C1=C(C=CC(=C1)/C=C\\2/C3=CC=CC=C3NC2=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4UNO2	Dithiobis(1H-indole-3-carboxamide) deriv. 10q	Investigative	5328608	C34H30N4O2S2	590.8	CC1=CC2=C(C=C1)C(=C(N2C)SSC3=C(C4=C(N3C)C=C(C=C4)C)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4W0HF	3-Substituted indolin-2-one 16g	Investigative	5329151	C25H24N2O4	416.5	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=C(C=C3)C4=CC(=CC=C4)OC)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B4ZJN5	(3-Imidazol-1-yl-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine	Investigative	11723151	C18H14N6	314.3	C1=CC(=CC(=C1)N2C=CN=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B50FEL	(3-Nitro-phenyl)-(4-pyridin-2-yl-pyrimidin-2-yl)-amine	Investigative	10708835	C15H11N5O2	293.28	C1=CC=NC(=C1)C2=NC(=NC=C2)NC3=CC(=CC=C3)[N+](=O)[O-]	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B53ECV	N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	9864718	C23H19N5O	381.4	CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 = 65000 nM	Poor binder
T59328	Epidermal growth factor receptor	B54FEV	1-Phenyl-3-[[5-(thiophen-3-ylmethyl)-1,3-thiazole-2-carbonyl]amino]urea	Investigative	57396795	C16H14N4O2S2	358.4	C1=CC=C(C=C1)NC(=O)NNC(=O)C2=NC=C(S2)CC3=CSC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B54TMQ	Methyl 2-(1-methyl-2-sulfanylidene-3H-indol-3-yl)acetate	Investigative	5328538	C12H13NO2S	235.3	CN1C2=CC=CC=C2C(C1=S)CC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B57BWQ	4-(2-Methoxyethyl)phenol	Investigative	92516	C9H12O2	152.19	COCCC1=CC=C(C=C1)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B58AZF	2-Thioxo-1H-indole-3-alkanoic acid deriv. 19	Investigative	5328549	C20H25NO6S	407.5	COC(=O)CCC1(C2=CC=CC=C2N(C1=S)CCC(=O)OC)CCC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B58TMC	[6-Chloro-4-methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate	Investigative	24753787	C21H22ClN3O6S	479.9	CC1=C(C(=O)OC2=CC(=C(C=C12)Cl)OC(=O)N(C)C)CC3=CC(=CC=C3)NS(=O)(=O)NC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5A0XM	3-Substituted indolin-2-one 11e	Investigative	5329142	C23H20N2O3	372.4	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=C(C=C(C=C3)C4=CC=CC=C4)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5A4VI	4-[Phenyl(methyl)amino]-5-anilinophthalimide	Investigative	10066030	C21H17N3O2	343.4	CN(C1=CC=CC=C1)C2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5CHJ4	N-[5-Methyl-1-[2-(prop-2-enoylamino)phenyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72699659	C25H19F3N4O2	464.4	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4=CC=CC=C4NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5D9YK	3-[3-(Benzothiazol-2-ylsulfanylmethyl)-4,5-dihydroxy-phenyl]-2-cyano-acrylamide	Investigative	44345327	C18H13N3O3S2	383.4	C1=CC=C2C(=C1)N=C(S2)SCC3=C(C(=CC(=C3)/C=C(\\C#N)/C(=O)N)O)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5F7YC	5-[(2,5-Dihydroxybenzylidene)amino]salicylic acid	Investigative	375472	C14H11NO5	273.24	C1=CC(=C(C=C1N=CC2=C(C=CC(=C2)O)O)C(=O)O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5G2JQ	5-(4-Amino-1-((piperidin-4-yl)methyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-chloropheno	Investigative	24905303	C17H19ClN6O	358.8	C1CNCCC1CN2C3=NC=NC(=C3C(=N2)C4=CC(=C(C=C4)Cl)O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5J9WE	N-(4-Anilino-5-chloro-9H-pyrimido[4,5-b]indol-2-yl)-2,2-dimethylpropanamide	Investigative	71583530	C21H20ClN5O	393.9	CC(C)(C)C(=O)NC1=NC2=C(C3=C(N2)C=CC=C3Cl)C(=N1)NC4=CC=CC=C4	IC50 = 114700 nM	Poor binder
T59328	Epidermal growth factor receptor	B5MAF6	N-(3-Bromophenyl)isoquinolin-1-amine	Investigative	4321095	C15H11BrN2	299.16	C1=CC=C2C(=C1)C=CN=C2NC3=CC(=CC=C3)Br	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5P6NG	4-Amino-7-(2-hydroxyethylamino)-5-methylpyrido[2,3-d]pyrimidine-6-carbonitrile	Investigative	56935338	C11H12N6O	244.25	CC1=C(C(=NC2=NC=NC(=C12)N)NCCO)C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5S3GE	N-Benzoyl-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide	Investigative	44273619	C30H23N5O2	485.5	CC1=C(C=C(C=C1)N(C(=O)C2=CC=CC=C2)C(=O)C3=CC=CC=C3)NC4=NC=CC(=N4)C5=CN=CC=C5	IC50 = 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5T0PQ	N-(3-Bromophenyl)-8,9-dimethoxy-N-methyl-5,6-dihydropyrimido[4,5-b][1,4]benzothiazepin-4-amine	Investigative	11583431	C20H19BrN4O2S	459.4	CN(C1=CC(=CC=C1)Br)C2=C3C(=NC=N2)SC4=CC(=C(C=C4CN3)OC)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5UOP1	4-N-(3-Bromophenyl)-7-[(4-chlorophenyl)methyl]pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	57394880	C19H15BrClN5	428.7	C1=CC(=CC(=C1)Br)NC2=C3C=CN(C3=NC(=N2)N)CC4=CC=C(C=C4)Cl	IC50 = 99900 nM	Poor binder
T59328	Epidermal growth factor receptor	B5X8EO	3-(2-Chloroquinolin-3-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905220	C17H15ClN6	338.8	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=CC=CC=C4N=C3Cl)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5XGQ0	2-Amino-4-(N-methyl-m-bromoanilino)-6-benzyl-pyrrolo[2,3-d]pyrimidine	Investigative	52948634	C20H18BrN5	408.3	CN(C1=CC(=CC=C1)Br)C2=NC(=NC3=C2C=C(N3)CC4=CC=CC=C4)N	IC50 = 53100 nM	Poor binder
T59328	Epidermal growth factor receptor	B5XSL9	N4-(3-Fluoro-4-trifluoromethylphenyl)-6-(2,4-dichlorobenzyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	46886974	C20H13Cl2F4N5	470.2	C1=CC(=C(C=C1NC2=NC(=NC3=C2C=C(N3)CC4=C(C=C(C=C4)Cl)Cl)N)F)C(F)(F)F	IC50 = 91700 nM	Poor binder
T59328	Epidermal growth factor receptor	B5YNV2	6,6-Dimethyl-8-(1-(oxetan-3-yl)piperidin-4-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile	Investigative	53357328	C27H27N3O2	425.5	CC1(C2=C(C=CC(=C2)C3CCN(CC3)C4COC4)C(=O)C5=C1NC6=C5C=CC(=C6)C#N)C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5ZV0X	Tyrphostin deriv. 64	Investigative	5328778	C18H16N2O5	340.3	COC1=CC(=C(C=C1)NC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N)OC	IC50 ~ 166000 nM	Poor binder
T59328	Epidermal growth factor receptor	B5ZV4X	3'-Chloro-7-hydroxyisoflavone	Investigative	10564143	C15H9ClO3	272.68	C1=CC(=CC(=C1)Cl)C2=COC3=C(C2=O)C=CC(=C3)O	IC50 = 58800 nM	Poor binder
T59328	Epidermal growth factor receptor	B60CAW	(R)-3-(6-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)quinolin-3-yl)acrylamide	Investigative	46232555	C20H15Cl2FN2O2	405.2	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=CC(=CN=C3C=C2)/C=C/C(=O)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B60PTO	1-Isopropyl-3-(2,4-dimethoxypyrimidin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905179	C14H17N7O2	315.33	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CN=C(N=C3OC)OC)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B62IEW	Ethyl 2-[5-[(2,5-dihydroxyphenyl)methylideneamino]-2-hydroxyphenyl]acetate	Investigative	135499946	C17H17NO5	315.32	CCOC(=O)CC1=C(C=CC(=C1)N=CC2=C(C=CC(=C2)O)O)O	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B62TCI	4-[4-[3-(Dimethylamino)-2-methylpropanoyl]phenoxy]sulfonylbenzoic acid;hydrochloride	Investigative	45260876	C19H22ClNO6S	427.9	CC(CN(C)C)C(=O)C1=CC=C(C=C1)OS(=O)(=O)C2=CC=C(C=C2)C(=O)O.Cl	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B63IXK	4-Amino-7-(2-hydroxyethylamino)pyrido[2,3-d]pyrimidine-6-carbonitrile	Investigative	56935337	C10H10N6O	230.23	C1=C(C(=NC2=NC=NC(=C21)N)NCCO)C#N	IC50 = 93300 nM	Poor binder
T59328	Epidermal growth factor receptor	B64EAB	6,7-Dialkoxyquinoline-3-carbonitrile deriv. 33	Investigative	5328865	C21H21N3O2	347.4	CC(C)C1=CC(=CC=C1)NC2=C(C=NC3=CC(=C(C=C32)OC)OC)C#N	IC50 = 61659.5 nM	Poor binder
T59328	Epidermal growth factor receptor	B69QLA	N-[5-Methyl-1-[4-(prop-2-enoylamino)cyclohexyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72700080	C25H25F3N4O2	470.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4CCC(CC4)NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6A0VO	5-(4-Amino-1-((5-methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenol	Investigative	24905307	C21H17FN8O	416.4	CC1=NN(N=C1CN2C3=NC=NC(=C3C(=N2)C4=CC(=C(C=C4)F)O)N)C5=CC=CC=C5	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6AN8L	1-[3-(Cyclohexylamino)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]prop-2-en-1-one	Investigative	76318480	C18H22N4OS	342.5	C=CC(=O)N1CCC2=C(C1)SC3=NC=NC(=C23)NC4CCCCC4	IC50 ~ 150000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6C9FG	(3Z)-3-[(4-Bromophenyl)methylidene]-1H-indol-2-one	Investigative	964113	C15H10BrNO	300.15	C1=CC=C2C(=C1)/C(=C/C3=CC=C(C=C3)Br)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6CG3F	5,21-Dihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione	Investigative	21197160	C26H21N3O9	519.5	C1=CC2=C(C(=C1)O)NC3=C4C(=C5C(=C23)C(=O)NC5=O)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C(=CC=C6)O	IC50 = 90000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6D5VG	8-(3,5-Dimethylanilino)-1-(3-morpholin-4-ylpropyl)-[1,3]oxazolo[4,5-g]quinazolin-2-one	Investigative	70690771	C24H27N5O3	433.5	CC1=CC(=CC(=C1)NC2=NC=NC3=CC4=C(C=C32)N(C(=O)O4)CCCN5CCOCC5)C	IC50 = 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6D8YQ	3-Substituted indolin-2-one 11g	Investigative	5329144	C24H22N2O4	402.4	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=C(C=C(C=C3)C4=CC=CC=C4OC)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6DAL3	Dithiobis(1H-indole-3-carboxamide) deriv. 10c	Investigative	5328594	C34H30N4O2S2	590.8	CC1=C2C(=CC=C1)N(C(=C2C(=O)NC3=CC=CC=C3)SSC4=C(C5=C(C=CC=C5N4C)C)C(=O)NC6=CC=CC=C6)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6EA5Z	Dimeric Tyrphostin 24	Investigative	5329272	C20H16N2O8S	444.4	COC1=CC(=CC(=C1O)O)/C=C(/S(=O)(=O)/C(=C/C2=CC(=C(C(=C2)OC)O)O)/C#N)\\C#N	IC50 ~ 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6ERQ3	1-Isopropyl-3-(2-methylquinolin-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905208	C18H18N6	318.4	CC1=NC2=C(C=C1)C=C(C=C2)C3=NN(C4=NC=NC(=C34)N)C(C)C	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6FO9B	N-[3-(4-Pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-nicotinamide	Investigative	9947433	C21H16N6O	368.4	C1=CC(=CC(=C1)NC(=O)C2=CN=CC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6FPS1	4-N-(3-Bromophenyl)-7-[(2-methylphenyl)methyl]pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	57396646	C20H18BrN5	408.3	CC1=CC=CC=C1CN2C=CC3=C(N=C(N=C32)N)NC4=CC(=CC=C4)Br	IC50 = 113300 nM	Poor binder
T59328	Epidermal growth factor receptor	B6G3XM	N'-(4-Chloro-2-methylphenyl)-4-ethylbenzohydrazide	Investigative	2811342	C16H17ClN2O	288.77	CCC1=CC=C(C=C1)C(=O)NNC2=C(C=C(C=C2)Cl)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6I1PT	N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-acetamide	Investigative	44273620	C18H17N5O	319.4	CC1=C(C=C(C=C1)NC(=O)C)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6J9NQ	4-Pyridin-4-yl-N-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]pyrimidin-2-amine	Investigative	9799152	C17H12F4N4O	364.3	C1=CC(=CC(=C1)OC(C(F)F)(F)F)NC2=NC=CC(=N2)C3=CC=NC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6JQ1V	3-[1-(4-Piperidin-1-yl-phenyl)-ethylidene]-1,3-dihydro-indol-2-one	Investigative	10663368	C21H22N2O	318.4	C/C(=C\\1/C2=CC=CC=C2NC1=O)/C3=CC=C(C=C3)N4CCCCC4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6LZ5N	3-(4-Dimethylamino-benzylidene)-4-methyl-1,3-dihydro-indol-2-one	Investigative	10755069	C18H18N2O	278.3	CC1=C\\2C(=CC=C1)NC(=O)/C2=C\\C3=CC=C(C=C3)N(C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6M8LA	(E)-2-Cyano-N-[[3-[[[(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]methyl]cyclohexyl]methyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide	Investigative	5329263	C28H28N4O6	516.5	C1CC(CC(C1)CNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N)CNC(=O)/C(=C/C3=CC(=C(C=C3)O)O)/C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6PQX3	2-Thioxo-1H-indole-3-carboxamide deriv. 13	Investigative	5328623	C22H18N2OS2	390.5	CN1C2=CC=CC=C2C(=C1SSC3=CC=CC=C3)C(=O)NC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6PZ0U	N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]naphthalene-2-carboxamide	Investigative	10181160	C27H21N5O	431.5	CC1=C(C=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C=C2)NC4=NC=CC(=N4)C5=CN=CC=C5	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6Q4YE	2-Cyano-3-[3-(6-ethoxy-benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-acrylamide	Investigative	44345353	C21H19N3O4S2	441.5	CCOC1=CC2=C(C=C1)N=C(S2)SCC3=C(C(=CC(=C3)/C=C(\\C#N)/C(=O)N)OC)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6R9FG	Dithiobis(1H-indole-3-carboxamide) deriv. 10d	Investigative	5328595	C34H30N4O4S2	622.8	CN1C2=C(C(=CC=C2)OC)C(=C1SSC3=C(C4=C(N3C)C=CC=C4OC)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6RP3V	N-[5-Methyl-1-[3-(prop-2-enoylamino)propyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72700006	C22H21F3N4O2	430.4	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)CCCNC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6S3WL	N-(3-Acetylphenyl)-1H-indole-2-carboxamide	Investigative	9209612	C17H14N2O2	278.3	CC(=O)C1=CC(=CC=C1)NC(=O)C2=CC3=CC=CC=C3N2	IC50 = 57000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6TJ7W	4-[(2-Chloro-6,7-dimethoxyquinazolin-4-yl)amino]benzenesulfonic acid	Investigative	22693031	C16H14ClN3O5S	395.8	COC1=C(C=C2C(=C1)C(=NC(=N2)Cl)NC3=CC=C(C=C3)S(=O)(=O)O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B6ZWA4	Ethyl 4-{[({5-[(4-methoxyanilino)methyl]-4-phenyl-4H-1,2,4-triazol-3-yl}sulfanyl)acetyl]amino}benzoate	Investigative	3135836	C27H27N5O4S	517.6	CCOC(=O)C1=CC=C(C=C1)NC(=O)CSC2=NN=C(N2C3=CC=CC=C3)CNC4=CC=C(C=C4)OC	IC50 = 92400 nM	Poor binder
T59328	Epidermal growth factor receptor	B72EBI	4-Dimethylamino-but-2-ynoic acid [4-(3-bromo-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide	Investigative	10906920	C23H20BrN5O2	478.3	CN(C)CC#CC(=O)NC1=C(C=C2C(=C1)C(=C(C=N2)C#N)NC3=CC(=CC=C3)Br)OC	IC50 = 90011.91 nM	Poor binder
T59328	Epidermal growth factor receptor	B72KOF	3N-Phenyl-2-(3-phenylcarbamoyl-1H-2-indolyldisulfanyl)-1H-3-indolecarboxamide	Investigative	10875157	C30H22N4O2S2	534.7	C1=CC=C(C=C1)NC(=O)C2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)C(=O)NC6=CC=CC=C6	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B73BAG	N-Butyl-4-(4-formylphenoxysulfonyl)benzamide	Investigative	14862538	C18H19NO5S	361.4	CCCCNC(=O)C1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)C=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B73CND	N-(4-Acetylphenyl)-1H-indole-2-carboxamide	Investigative	26699441	C17H14N2O2	278.3	CC(=O)C1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3N2	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B73ZVH	2-N-[3-Methyl-4-(4-methylpiperazin-1-yl)phenyl]-4-N-(3-methylphenyl)pyrimidine-2,4-diamine	Investigative	134131586	C23H28N6	388.5	CC1=CC(=CC=C1)NC2=NC(=NC=C2)NC3=CC(=C(C=C3)N4CCN(CC4)C)C	IC50 ~ 150000 nM	Poor binder
T59328	Epidermal growth factor receptor	B74OWN	3-[1-(4-Piperidin-1-yl-phenyl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one	Investigative	9948410	C20H20N2O	304.4	C1CCN(CC1)C2=CC=C(C=C2)/C=C\\3/C4=CC=CC=C4NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B78MUR	5-[(1E)-2-(5,6-Dibromo-3-ethoxy-2-hydroxyphenyl)-1-azavinyl]-3-hydrobenzimidaz ol-2-one	Investigative	1128774	C16H13Br2N3O3	455.1	CCOC1=CC(=C(C(=C1O)C=NC2=CC3=C(C=C2)NC(=O)N3)Br)Br	IC50 = 76700 nM	Poor binder
T59328	Epidermal growth factor receptor	B78RHA	(3Z)-3-[4-(Morpholin-4-yl)benzylidene]-1,3-dihydro-2H-indol-2-one	Investigative	2379240	C19H18N2O2	306.4	C1COCCN1C2=CC=C(C=C2)/C=C\\3/C4=CC=CC=C4NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B79BVW	2-(2-Imino-4-phenyl-1,3-thiazol-3-yl)-1-morpholin-4-ylethanone	Investigative	73346521	C15H17N3O2S	303.4	C1COCCN1C(=O)CN2C(=CSC2=N)C3=CC=CC=C3	Ki = 55290 nM	Poor binder
T59328	Epidermal growth factor receptor	B79PUS	2-[[3-(Diethoxyphosphorylmethyl)-4-hydroxyanilino]methyl]benzene-1,4-diol	Investigative	10317696	C18H24NO6P	381.4	CCOP(=O)(CC1=C(C=CC(=C1)NCC2=C(C=CC(=C2)O)O)O)OCC	IC50 = 70000 nM	Poor binder
T59328	Epidermal growth factor receptor	B79PYV	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(3-fluoro-phenyl)-amine	Investigative	10729749	C14H13FN4	256.279	CC1=C(NC2=C1C(=NC=N2)NC3=CC(=CC=C3)F)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7BO5D	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(2-ethyl-phenyl)-amine	Investigative	13492283	C16H18N4	266.34	CCC1=CC=CC=C1NC2=NC=NC3=C2C(=C(N3)C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7BZJ1	2-Cyano-2-(3,4-dihydroxy-benzyl)-thioacetamide	Investigative	44318047	C10H10N2O2S	222.27	C1=CC(=C(C=C1CC(C#N)C(=S)N)O)O	IC50 = 70000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7FEH4	Methyl 3-{1-methyl-2-[1-methyl-3-(3-methyloxycarbonylphenylcarbamoyl)-1H-2-indolyldisulfanyl]-1H-3-indolylcarboxamido}benzoate	Investigative	10327196	C36H30N4O6S2	678.8	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CC=CC(=C5)C(=O)OC)C(=O)NC6=CC=CC(=C6)C(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7FI8U	Chembl4214588	Investigative	142747612	C22H18N4O3	386.4	COC(=O)C1=CC(=C(C=C1)O)C2=NC3=CC=CC=C3C(=N2)NCC4=CN=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7IGT0	(E)-2-Cyano-3-[3-(4,5-dihydro-thiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-acrylamide	Investigative	44345288	C15H15N3O3S2	349.4	COC1=CC(=CC(=C1O)CSC2=NCCS2)/C=C(\\C#N)/C(=O)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7ITV4	N-[3-[(3-Cyano-6,7-dimethoxyquinolin-4-yl)amino]phenyl]acetamide	Investigative	5328872	C20H18N4O3	362.4	CC(=O)NC1=CC=CC(=C1)NC2=C(C=NC3=CC(=C(C=C32)OC)OC)C#N	IC50 = 69183.1 nM	Poor binder
T59328	Epidermal growth factor receptor	B7IZ3T	N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-2-methoxy-acetamide	Investigative	10318022	C17H15BrN4O2	387.2	COCC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7J1GF	7-((4-Methylpiperazin-1-yl)methyl)-3-(thiophen-3-yl)-1,4-dihydroindeno[1,2-c]pyrazole	Investigative	44414347	C20H22N4S	350.5	CN1CCN(CC1)CC2=CC3=C(CC4=C3NN=C4C5=CSC=C5)C=C2	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7J9UL	Piperonylidenemalononitrile	Investigative	18091	C11H6N2O2	198.18	C1OC2=C(O1)C=C(C=C2)C=C(C#N)C#N	Ki = 117000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7JU9T	Sdz-lap-977	Investigative	9818362	C18H20O5	316.3	COC1=CC(=C(C=C1)OC)CCC2=CC(=C(C=C2)O)C(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7M1FV	4',6,8-Triamino-7-hydroxyflavone	Investigative	10356450	C15H13N3O3	283.28	C1=CC(=CC=C1C2=CC(=O)C3=CC(=C(C(=C3O2)N)O)N)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7N1WR	3-[(E)-2-(4-Chlorophenyl)ethenyl]-N-[(2S)-2,3-dihydroxypropyl]-4-methoxybenzamide	Investigative	57325479	C19H20ClNO4	361.8	COC1=C(C=C(C=C1)C(=O)NC[C@@H](CO)O)/C=C/C2=CC=C(C=C2)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7QS8U	2-[[5,13-Diamino-11-(2-hydroxyethylamino)-4-thia-8,10,12-triazatricyclo[7.4.0.02,6]trideca-1(13),2,5,7,9,11-hexaen-7-yl]amino]ethanol	Investigative	56649610	C13H17N7O2S	335.39	C1=C2C3=C(N=C(N=C3N=C(C2=C(S1)N)NCCO)NCCO)N	IC50 = 66100 nM	Poor binder
T59328	Epidermal growth factor receptor	B7S1XJ	4-(4-Amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-2-chlorobenzamide	Investigative	52942235	C15H15ClN6O	330.77	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC(=C(C=C3)C(=O)N)Cl)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7SR2T	1-Butyl-1-(2-hydroxy-3,5-dimethylbenzyl)-3-phenylurea	Investigative	46229464	C20H26N2O2	326.4	CCCCN(CC1=CC(=CC(=C1O)C)C)C(=O)NC2=CC=CC=C2	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7TOG3	5-Nitro-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one	Investigative	10658651	C13H9N3O3	255.23	C1=CNC(=C1)/C=C\\2/C3=C(C=CC(=C3)[N+](=O)[O-])NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7TW8G	4-([r]-1-Phenylethylamino)indolo[3,2-d]pyrimidine hydrochloride	Investigative	70023804	C18H17ClN4	324.8	C[C@H](C1=CC=CC=C1)NC2=NC=NC3=C2NC4=CC=CC=C43.Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7TYQ5	2-[5-(2,2-Dicyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-benzoic acid	Investigative	44345309	C19H14N2O4S	366.4	COC1=CC(=CC(=C1O)CSC2=CC=CC=C2C(=O)O)C=C(C#N)C#N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7UM1H	Propanedinitrile, ((4-hydroxy-3-nitrophenyl)methylene)-	Investigative	5328785	C10H5N3O3	215.16	C1=CC(=C(C=C1C=C(C#N)C#N)[N+](=O)[O-])O	IC50 = 125000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7VIZ5	Tert-butyl N-[(2R)-1-[[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]amino]-1-oxopropan-2-yl]carbamate	Investigative	134827836	C22H23ClFN5O3	459.9	C[C@H](C(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7X8DU	N-[4-Chloro-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide	Investigative	44273476	C22H16ClN5O	401.8	C1=CC=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7Z2YV	Di(3-phenyl-1H-2-indolyl) disulfide	Investigative	15249955	C28H20N2S2	448.6	C1=CC=C(C=C1)C2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)C6=CC=CC=C6	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B7ZDB8	(R)-6-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)quinoline	Investigative	46232443	C17H12Cl2FNO	336.2	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=C(C=C2)N=CC=C3	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B81FOM	Indolin-2-one deriv. 9h	Investigative	5329170	C27H26N2O4	442.5	COC1=CC=CC=C1C2=CC3=C(C=C2)/C(=C/C4=C(C5=C(N4)CCCC5)CCC(=O)O)/C(=O)N3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B82SYO	3-(5-((6-(3,5-Dimethoxyphenyl)-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrol-3-yl)propanoic acid	Investigative	23625758	C26H26N2O5	446.5	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=C(C=C3)C4=CC(=CC(=C4)OC)OC)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B83RXF	2-Thioxo-1H-indole-3-alkanoic acid deriv. 17	Investigative	5328547	C14H15NO4S	293.34	C1=CC=C2C(=C1)C(C(=S)N2)(CCC(=O)O)CCC(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B85NMA	7-Aminopyrido[4,3-d]pyrimidine 8s	Investigative	5328095	C16H18N6	294.35	CN(C)C1=CC=C(C=C1)CNC2=NC=NC3=CC(=NC=C32)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B86KGW	(E)-2-Cyano-3-(3,5-dibutyl-4-hydroxyphenyl)prop-2-enamide	Investigative	44315416	C18H24N2O2	300.4	CCCCC1=CC(=CC(=C1O)CCCC)/C=C(\\C#N)/C(=O)N	IC50 = 55000 nM	Poor binder
T59328	Epidermal growth factor receptor	B87IKZ	1-Methyl-N-phenyl-2-sulfanylidene-3H-pyrrolo[2,3-b]pyridine-3-carboxamide	Investigative	5328620	C15H13N3OS	283.4	CN1C(=S)C(C2=C1N=CC=C2)C(=O)NC3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8BQ0O	1,4-Diphenyl-1,2,3,4-tetrahydro-pyrrolo[3,4-g]quinoxaline-6,8-dione	Investigative	10450849	C22H17N3O2	355.4	C1CN(C2=C(N1C3=CC=CC=C3)C=C4C(=C2)C(=O)NC4=O)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8DXQ3	2-[5-[(2,5-Dihydroxyphenyl)methylideneamino]-2-hydroxyphenyl]-N-phenylmethoxyacetamide	Investigative	135464283	C22H20N2O5	392.4	C1=CC=C(C=C1)CONC(=O)CC2=C(C=CC(=C2)N=CC3=C(C=CC(=C3)O)O)O	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8G9NA	(E)-2-Cyano-N-[2-[[(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]ethyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide	Investigative	5329256	C22H18N4O6	434.4	C1=CC(=C(C=C1/C=C(/C(=O)NCCNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N)\\C#N)O)O	IC50 = 113000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8LJS5	3-(5-Methyl-furan-2-ylmethylene)-1,3-dihydro-indol-2-one	Investigative	2358462	C14H11NO2	225.24	CC1=CC=C(O1)/C=C/2\\C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8N9VS	(3Z)-4-Methyl-3-(1H-pyrrol-2-ylmethylidene)-2,3-dihydro-1H-indol-2-one	Investigative	10489322	C14H12N2O	224.26	CC1=C\\2C(=CC=C1)NC(=O)/C2=C\\C3=CC=CN3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8Q7IB	2-Methoxy-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10157645	C23H19N5O2	397.4	COC1=CC=CC=C1C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8QUZ0	6,7-Dimethoxyisoquinoline-4-carbonitrile deriv. 61	Investigative	5328885	C18H14BrN3O2	384.2	COC1=C(C=C2C(=C1)C(=CN=C2NC3=CC(=CC=C3)Br)C#N)OC	IC50 = 70794.58 nM	Poor binder
T59328	Epidermal growth factor receptor	B8T1KO	7-Benzyl-4-N-(3-bromophenyl)pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	57394879	C19H16BrN5	394.3	C1=CC=C(C=C1)CN2C=CC3=C(N=C(N=C32)N)NC4=CC(=CC=C4)Br	IC50 = 166400 nM	Poor binder
T59328	Epidermal growth factor receptor	B8USO3	3-[(Z)-(3-Bromo-2-thienyl)methylidene]-1H-indol-2-one	Investigative	5707304	C13H8BrNOS	306.18	C1=CC=C2C(=C1)/C(=C/C3=C(C=CS3)Br)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8WJ6T	Dithiobis(1H-indole-3-carboxamide) deriv. 10i	Investigative	5328600	C34H30N4O2S2	590.8	CC1=CC2=C(C=C1)N(C(=C2C(=O)NC3=CC=CC=C3)SSC4=C(C5=C(N4C)C=CC(=C5)C)C(=O)NC6=CC=CC=C6)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B8YTQ3	CID 49806721	Investigative	49806721	C28H30N4O2	454.6	CCC1=CC2=C(C=C1N3CCN(CC3)C4COC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B93ILO	9H-Imidazo(4,5-H)isoquinolin-9-one, 2-((2,6-dichlorophenyl)amino)-1,8-dihydro-6,7-dimethyl-	Investigative	10248747	C18H14Cl2N4O	373.2	CC1=C(NC(=O)C2=C1C=CC3=C2N=C(N3)NC4=C(C=CC=C4Cl)Cl)C	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B97RPS	Serotonin hydrochloride	Investigative	160436	C10H13ClN2O	212.67	C1=CC2=C(C=C1O)C(=CN2)CCN.Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9AY3X	Azobenzene-2,4,4'-triol	Investigative	135469322	C12H10N2O3	230.22	C1=CC(=CC=C1N=NC2=C(C=C(C=C2)O)O)O	IC50 = 58000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9CJ5N	Methyl 2-[5-[(2,5-dihydroxyphenyl)methylideneamino]-2-hydroxyphenyl]acetate	Investigative	135516745	C16H15NO5	301.29	COC(=O)CC1=C(C=CC(=C1)N=CC2=C(C=CC(=C2)O)O)O	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9CU5F	7-Hydroxy-2-[[7-hydroxy-1-methyl-3-(phenylcarbamoyl)indol-2-yl]disulfanyl]-1-methyl-N-phenylindole-3-carboxamide	Investigative	5328616	C32H26N4O4S2	594.7	CN1C2=C(C=CC=C2O)C(=C1SSC3=C(C4=C(N3C)C(=CC=C4)O)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9DEP0	1-Methyl-2-[[1-methyl-3-(thiophen-2-ylcarbamoyl)indol-2-yl]disulfanyl]-N-thiophen-2-ylindole-3-carboxamide	Investigative	10076837	C28H22N4O2S4	574.8	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CC=CS5)C(=O)NC6=CC=CS6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9FAW1	4-[[5,13-Diamino-11-(2-hydroxyethylamino)-4-thia-8,10,12-triazatricyclo[7.4.0.02,6]trideca-1(13),2,5,7,9,11-hexaen-7-yl]amino]benzenesulfonamide	Investigative	57392009	C17H18N8O3S2	446.5	C1=CC(=CC=C1NC2=NC3=NC(=NC(=C3C4=CSC(=C42)N)N)NCCO)S(=O)(=O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9G1IO	Arcyriaflavin a	Investigative	5327723	C20H11N3O2	325.3	C1=CC=C2C(=C1)C3=C4C(=C5C6=CC=CC=C6NC5=C3N2)C(=O)NC4=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9JS4G	4-Hydroxy-8-methoxy-6-methyl-2H-pyrano[3,2-c]quinoline-2,5(6H)-dione	Investigative	54708982	C14H11NO5	273.24	CN1C2=C(C=CC(=C2)OC)C3=C(C1=O)C(=CC(=O)O3)O	IC50 = 76400 nM	Poor binder
T59328	Epidermal growth factor receptor	B9MO5H	N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine	Investigative	9965429	C16H15N5	277.32	CC1=C(C=C(C=C1)N)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9NE7Q	alpha-Cyano-4-hydroxycinnamic acid	Investigative	5328791	C10H7NO3	189.17	C1=CC(=CC=C1/C=C(\\C#N)/C(=O)O)O	IC50 = 165000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9OES1	1-(3-(8-(Pyridin-4-ylmethylamino)imidazo[1,2-a]pyrazin-6-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea	Investigative	11755812	C26H20F3N7O	503.5	C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(F)(F)F)C3=CN4C=CN=C4C(=N3)NCC5=CC=NC=C5	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9S1QD	1-[5,21-Dihydroxy-12,14-dioxo-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaen-13-yl]-3-phenylurea	Investigative	44273528	C33H27N5O10	653.6	C1=CC=C(C=C1)NC(=O)NN2C(=O)C3=C4C5=C(C(=CC=C5)O)NC4=C6C(=C3C2=O)C7=C(N6C8C(C(C(C(O8)CO)O)O)O)C(=CC=C7)O	IC50 = 95000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9SBE8	2-Thioxo-1H-indole-3-alkanoic acid deriv. 18	Investigative	5328548	C16H19NO4S	321.4	COC(=O)CCC1(C2=CC=CC=C2NC1=S)CCC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9SP2F	(3-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)methanol	Investigative	24905344	C15H17N5O	283.33	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC=CC(=C3)CO)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9TN2O	6-(2,4-Dihydroxyphenyl)-4-methyl-2-(3-methyl-5-oxo-4-(thiophen-2-ylmethylene)-4,5-dihydro-1H-pyrazol-1-yl)-N-(3-nitrophenyl)-1,6-dihydropyrimidine-5-carboxamide	Investigative	45276458	C27H22N6O6S	558.6	CC1=C(C(N=C(N1)N2C(=O)/C(=C/C3=CC=CS3)/C(=N2)C)C4=C(C=C(C=C4)O)O)C(=O)NC5=CC(=CC=C5)[N+](=O)[O-]	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9U1MG	6,7-Dimethoxyisoquinoline-4-carbonitrile deriv. 62	Investigative	5328886	C18H14ClN3O2	339.8	COC1=C(C=C2C(=C1)C(=CN=C2NC3=CC(=CC=C3)Cl)C#N)OC	IC50 = 89125.09 nM	Poor binder
T59328	Epidermal growth factor receptor	B9V1IQ	3-[5-(2-Chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-phenylquinazolin-4-one	Investigative	137645832	C22H13ClN4OS	416.9	C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=O)N2C4=NN=C(S4)C5=CC=CC=C5Cl	IC50 = 78230 nM	Poor binder
T59328	Epidermal growth factor receptor	B9WC3V	2-Thioxo-1H-indole-3-carboxamide deriv. 11	Investigative	5328621	C17H16N2OS	296.4	CC1(C2=CC=CC=C2N(C1=S)C)C(=O)NC3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	B9ZB2K	4,5-Bis[4-(diethylamino)anilino]phthalimide	Investigative	10434923	C28H33N5O2	471.6	CCN(CC)C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)N(CC)CC	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BA12XG	N-Benzyl-3-(2-sulfanylidene-1,3-dihydroindol-3-yl)propanamide	Investigative	5328591	C18H18N2OS	310.4	C1=CC=C(C=C1)CNC(=O)CCC2C3=CC=CC=C3NC2=S	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BA9F5S	5-(4-Amino-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-bromophenol	Investigative	24905331	C12H10BrN5O	320.14	CN1C2=NC=NC(=C2C(=N1)C3=CC(=C(C=C3)Br)O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BACY73	(3Z)-3-(4-Hydroxybenzylidene)-1,3-dihydro-2H-indol-2-one	Investigative	5874584	C15H11NO2	237.25	C1=CC=C2C(=C1)/C(=C/C3=CC=C(C=C3)O)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BAHS79	[5-(2,2-Dicyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-acetic acid	Investigative	44345676	C14H12N2O4S	304.32	COC1=CC(=CC(=C1O)CSCC(=O)O)C=C(C#N)C#N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BAK94N	[5-[(2,5-Dihydroxyphenyl)methylamino]-2-hydroxyphenyl]methylphosphonic acid	Investigative	10041970	C14H16NO6P	325.25	C1=CC(=C(C=C1NCC2=C(C=CC(=C2)O)O)CP(=O)(O)O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BAKB47	2-(1H-Indol-5-ylmethylidene)propanedinitrile	Investigative	5328751	C12H7N3	193.2	C1=CC2=C(C=CN2)C=C1C=C(C#N)C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BAX8B9	N-(3-Bromophenyl)quinoxalin-2-amine	Investigative	5328022	C14H10BrN3	300.15	C1=CC=C2C(=C1)N=CC(=N2)NC3=CC(=CC=C3)Br	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BAY59B	Indolin-2-one deriv. 9b	Investigative	5329164	C20H19BrN2O3	415.3	C1CCC2=C(C1)C(=C(N2)/C=C\\3/C4=C(C=CC(=C4)Br)NC3=O)CCC(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BB1R9F	2-(Benzylsulfonyl)-4-(2,4-dihydroxyphenyl)-6-methyl-N-p-tolylpyrimidine-5-carboxamide	Investigative	135883350	C26H23N3O5S	489.5	CC1=CC=C(C=C1)NC(=O)C2=C(N=C(N=C2C3=C(C=C(C=C3)O)O)S(=O)(=O)CC4=CC=CC=C4)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BB2S4A	2-((4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one	Investigative	24905149	C28H23N7O2	489.5	CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C5=NC=NC(=C5C(=N4)C6=CC(=CC=C6)O)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BB3F1P	Dithiobis(1H-indoles) deriv. 4	Investigative	5328097	C36H36N6O2S2	648.8	C1=CC=C(C=C1)CNC(=O)C(CC2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)CC(C(=O)NCC6=CC=CC=C6)N)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BB45OF	Indolin-2-one deriv. 4h	Investigative	5329161	C24H22N2O2	370.4	COC1=CC=CC=C1C2=CC3=C(C=C2)/C(=C/C4=CC5=C(N4)CCCC5)/C(=O)N3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BB4D1Z	N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine	Investigative	10686149	C16H13N5O2	307.31	CC1=C(C=C(C=C1)[N+](=O)[O-])NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BB7SV5	1-[4-(4-Amino-6-methylthieno[2,3-d]pyrimidin-5-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea	Investigative	6540005	C21H15F4N5OS	461.4	CC1=C(C2=C(N=CN=C2S1)N)C3=CC=C(C=C3)NC(=O)NC4=C(C=CC(=C4)C(F)(F)F)F	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BBH65Q	4,5-Bis(cyclohexylamino)phthalimide	Investigative	10450005	C20H27N3O2	341.4	C1CCC(CC1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4CCCCC4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BBW31R	N-(4-Pyridin-3-yl-pyrimidin-2-yl)-benzene-1,3-diamine	Investigative	9943194	C15H13N5	263.3	C1=CC(=CC(=C1)NC2=NC=CC(=N2)C3=CN=CC=C3)N	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BBX8L6	4-N-[(2-Methoxyphenyl)methyl]pyrido[4,3-d]pyrimidine-4,7-diamine	Investigative	5328087	C15H15N5O	281.31	COC1=CC=CC=C1CNC2=NC=NC3=CC(=NC=C32)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BBZ51F	3-Substituted indolin-2-one 11a	Investigative	5329138	C17H16N2O3	296.32	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC1DT7	Chembl4207984	Investigative	142747584	C21H15N5O	353.4	C1=CC=C2C(=C1)C(=NC(=N2)C3=C(C=CC(=C3)C#N)O)NCC4=CN=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC47JN	4-Amino-3-prop-2-enyl-2-sulfanylidene-N-[(E)-thiophen-2-ylmethylideneamino]-1,3-thiazole-5-carboxamide	Investigative	9583801	C12H12N4OS3	324.5	C=CCN1C(=C(SC1=S)C(=O)N/N=C/C2=CC=CS2)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC4ME8	Chembl4218431	Investigative	142747615	C20H14N6O	354.4	C1=CC=C2C(=C1)C(=NC(=N2)C3=C(C=CC(=C3)C#N)O)NCC4=NC=CN=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC6L3W	4-Amino-2-[5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]phenol	Investigative	137653795	C16H13N5O2	307.31	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)C4=C(C=CC(=C4)N)O	IC50 = 69984.2 nM	Poor binder
T59328	Epidermal growth factor receptor	BC7XP0	6-(2,4-Dihydroxyphenyl)-2-(4-(furan-2-ylmethylene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)-4-methyl-N-(3-nitrophenyl)-1,6-dihydropyrimidine-5-carboxamide	Investigative	45276457	C27H22N6O7	542.5	CC1=C(C(N=C(N1)N2C(=O)/C(=C/C3=CC=CO3)/C(=N2)C)C4=C(C=C(C=C4)O)O)C(=O)NC5=CC(=CC=C5)[N+](=O)[O-]	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC87JM	(Z)-4-Methyl-3-(4-morpholinobenzylidene)indolin-2-one	Investigative	10663503	C20H20N2O2	320.4	CC1=C\\2C(=CC=C1)NC(=O)/C2=C\\C3=CC=C(C=C3)N4CCOCC4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC8Q2X	2-[5,6-Dimethyl-3-(4-methylphenyl)-4-oxo(3-hydrothiopheno[2,3-d]pyrimidin-2-yl thio)]-N-(2-chlorophenyl)acetamide	Investigative	3138425	C23H20ClN3O2S2	470	CC1=CC=C(C=C1)N2C(=O)C3=C(N=C2SCC(=O)NC4=CC=CC=C4Cl)SC(=C3C)C	IC50 = 81600 nM	Poor binder
T59328	Epidermal growth factor receptor	BC8XV0	[4-(4-Chloro-phenyl)-pyrimidin-2-yl]-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-amine	Investigative	19966997	C18H12ClF4N3O	397.8	C1=CC(=CC(=C1)OC(C(F)F)(F)F)NC2=NC=CC(=N2)C3=CC=C(C=C3)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC9NA6	N-[3-[(4-Pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	11440028	C22H17N5O	367.4	C1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BC9U7X	(3Z)-3-[(4-Methoxyphenyl)methylidene]-1H-indol-2-one	Investigative	727518	C16H13NO2	251.28	COC1=CC=C(C=C1)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BCD65W	2-Cyano-N-(3-((2-cyano-3-(3,4-dihydroxy-5-(hydroxy(oxido)amino)phenyl)acryloyl)amino)propyl)-3-(3,4-dihydroxy-5-(hydroxy(oxido)amino)phenyl)acrylamide	Investigative	6082393	C23H18N6O10	538.4	C1=C(C=C(C(=C1[N+](=O)[O-])O)O)/C=C(/C(=O)NCCCNC(=O)/C(=C/C2=CC(=C(C(=C2)O)O)[N+](=O)[O-])/C#N)\\C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BCF13G	Tert-butyl 6-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)quinolin-4-ylcarbamate	Investigative	24905231	C22H25N7O2	419.5	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=CN=C4C=C3)NC(=O)OC(C)(C)C)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BCL18F	Methyl 2-{1-methyl-2-[1-methyl-3-(2-methyloxycarbonylphenylcarbamoyl)-1H-2-indolyldisulfanyl]-1H-3-indolylcarboxamido}benzoate0.5 H2O	Investigative	10032479	C36H30N4O6S2	678.8	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CC=CC=C5C(=O)OC)C(=O)NC6=CC=CC=C6C(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BCL1D4	N-(4-Bromophenyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxamide	Investigative	10457505	C21H22BrN5O3	472.3	COC1=C(C=C2C(=C1)C(=NC=N2)N3CCN(CC3)C(=O)NC4=CC=C(C=C4)Br)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BCS86E	4-N-(4-Chloro-2-fluorophenyl)-6-(naphthalen-1-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	56951305	C23H17ClFN5	417.9	C1=CC=C2C(=C1)C=CC=C2CC3=CC4=C(N3)N=C(N=C4NC5=C(C=C(C=C5)Cl)F)N	IC50 = 112100 nM	Poor binder
T59328	Epidermal growth factor receptor	BCVT06	2-Thioxo-1H-indole-3-carboxamide deriv. 14	Investigative	5328624	C23H20N2OS2	404.6	CN1C2=CC=CC=C2C(=C1SSCC3=CC=CC=C3)C(=O)NC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BCWX43	4-[(2-Chloroquinazolin-4-yl)amino]-N,N-dimethylbenzenesulfonamide	Investigative	76317238	C16H15ClN4O2S	362.8	CN(C)S(=O)(=O)C1=CC=C(C=C1)NC2=NC(=NC3=CC=CC=C32)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BCYW21	N-[1-(4-Hydroxycyclohexyl)-6-methylbenzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	134132335	C22H22F3N3O2	417.4	CC1=CC2=C(C=C1)N=C(N2C3CCC(CC3)O)NC(=O)C4=CC(=CC=C4)C(F)(F)F	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD01AP	4-Methyl-3-(5-methylsulfanyl-thiophen-2-ylmethylene)-1,3-dihydro-indol-2-one	Investigative	10779668	C15H13NOS2	287.4	CC1=C\\2C(=CC=C1)NC(=O)/C2=C\\C3=CC=C(S3)SC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD05ME	(Z)-4-(4-((4-Methyl-2-oxoindolin-3-ylidene)methyl)phenyl)piperazine-1-carbaldehyde	Investigative	10593765	C21H21N3O2	347.4	CC1=C\\2C(=CC=C1)NC(=O)/C2=C\\C3=CC=C(C=C3)N4CCN(CC4)C=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD0K7N	N-[4-(3-Bromoanilino)-3-cyano-7-methoxyquinolin-6-yl]but-2-ynamide	Investigative	9803006	C21H15BrN4O2	435.3	CC#CC(=O)NC1=C(C=C2C(=C1)C(=C(C=N2)C#N)NC3=CC(=CC=C3)Br)OC	IC50 = 190020.3 nM	Poor binder
T59328	Epidermal growth factor receptor	BD17KR	(3Z)-3-[(4-Chloro-1-methylpyrazol-3-yl)methylidene]-1H-indol-2-one	Investigative	136026516	C13H10ClN3O	259.69	CN1C=C(C(=N1)/C=C\\2/C3=CC=CC=C3NC2=O)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD2OM6	3-Substituted indolin-2-one 9a	Investigative	5329134	C18H18N2O3	310.3	CC1=C\\2C(=CC=C1)NC(=O)/C2=C\\C3=C(C(=CN3)C)CCC(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD35UN	N-(3-Chloro-2-fluorophenyl)-8,9-dimethoxy-2-methyl-5,6-dihydropyrimido[4,5-b][1,4]benzothiazepin-4-amine	Investigative	11640601	C20H18ClFN4O2S	432.9	CC1=NC(=C2C(=N1)SC3=CC(=C(C=C3CN2)OC)OC)NC4=C(C(=CC=C4)Cl)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD3J0Y	2-(Benzylsulfonyl)-4-(2,4-dihydroxyphenyl)-6-methyl-N-(3-nitrophenyl)pyrimidine-5-carboxamide	Investigative	135883354	C25H20N4O7S	520.5	CC1=C(C(=NC(=N1)S(=O)(=O)CC2=CC=CC=C2)C3=C(C=C(C=C3)O)O)C(=O)NC4=CC(=CC=C4)[N+](=O)[O-]	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD60GI	2-(3,4-Dihydroxy-5-methylbenzylidene)malononitrile	Investigative	9899125	C11H8N2O2	200.19	CC1=CC(=CC(=C1O)O)C=C(C#N)C#N	IC50 = 61659.5 nM	Poor binder
T59328	Epidermal growth factor receptor	BD71KR	N-[5-Methyl-1-[3-(prop-2-enoylamino)cyclopentyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72700004	C24H23F3N4O2	456.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4CCC(C4)NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BD7V3U	2-[5-(1H-Benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]acetonitrile	Investigative	137633245	C12H9N5O	239.23	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)CC#N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BDG2H1	3',6-Diamino-7-hydroxyflavone	Investigative	10265006	C15H12N2O3	268.27	C1=CC(=CC(=C1)N)C2=CC(=O)C3=CC(=C(C=C3O2)O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BDJU98	1-Isopropyl-3-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905170	C13H14N6	254.29	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CN=CC=C3)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BDQS26	4-N-(3-Bromophenyl)-7-[(2,5-dimethoxyphenyl)methyl]pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	57398417	C21H20BrN5O2	454.3	COC1=CC(=C(C=C1)OC)CN2C=CC3=C(N=C(N=C32)N)NC4=CC(=CC=C4)Br	IC50 = 69200 nM	Poor binder
T59328	Epidermal growth factor receptor	BDV8X5	4-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-benzenesulfonamide	Investigative	24905338	C14H16N6O2S	332.38	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC=C(C=C3)S(=O)(=O)N)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BE13BX	N-[3-[(4-Pyridin-3-ylpyrimidin-2-yl)amino]phenyl]thiophene-2-carboxamide	Investigative	11280238	C20H15N5OS	373.4	C1=CC(=CC(=C1)NC(=O)C2=CC=CS2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BE2HM6	N-(4-Chlorophenyl)-2-[[2-(4-chlorophenyl)-6-oxo-1H-1,3,5-triazin-4-yl]sulfanyl]acetamide	Investigative	2744121	C17H12Cl2N4O2S	407.3	C1=CC(=CC=C1C2=NC(=NC(=O)N2)SCC(=O)NC3=CC=C(C=C3)Cl)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BE5CD3	4',8-Diamino-6-methoxyflavone	Investigative	10085171	C16H14N2O3	282.29	COC1=CC2=C(C(=C1)N)OC(=CC2=O)C3=CC=C(C=C3)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BE63UG	4,N*1*-Dimethyl-N*3*-(4-pyridin-3-yl-pyrimidin-2-yl)-benzene-1,3-diamine	Investigative	44273595	C17H17N5	291.35	CC1=C(C=C(C=C1)NC)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BE8IC3	1-N-(6-Chloro-[1,3]dioxolo[4,5-g]quinazolin-8-yl)-4-N,4-N-dimethylbenzene-1,4-diamine	Investigative	76335419	C17H15ClN4O2	342.8	CN(C)C1=CC=C(C=C1)NC2=NC(=NC3=CC4=C(C=C32)OCO4)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BE8O6C	N-[3-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-phenyl]-methanesulfonamide	Investigative	24905159	C15H18N6O2S	346.4	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC(=CC=C3)NS(=O)(=O)C)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BE9C0U	N4-(2-Isopropylphenyl)-6-(2,4-dichlorobenzyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	46887039	C22H21Cl2N5	426.3	CC(C)C1=CC=CC=C1NC2=NC(=NC3=C2C=C(N3)CC4=C(C=C(C=C4)Cl)Cl)N	IC50 = 96400 nM	Poor binder
T59328	Epidermal growth factor receptor	BE9MA7	4-Cyano-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10111108	C23H16N6O	392.4	C1=CC(=CC(=C1)NC(=O)C2=CC=C(C=C2)C#N)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BED3J2	2-(1-Methyl-2-sulfanylidene-3H-indol-3-yl)acetic acid	Investigative	5328536	C11H11NO2S	221.28	CN1C2=CC=CC=C2C(C1=S)CC(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEI61N	2-[(4-Formylphenyl)methylidene]propanedinitrile	Investigative	5328787	C11H6N2O	182.18	C1=CC(=CC=C1C=C(C#N)C#N)C=O	IC50 = 60000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEID83	6-(2,6-Dichlorophenyl)-2-(dimethylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one	Investigative	5327875	C16H14Cl2N4O	349.2	CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)N(C)C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEJ7N0	Tert-butyl N-[4-[[4-(3-chloroanilino)-2H-pyrazolo[3,4-d]pyrimidin-3-yl]amino]phenyl]carbamate	Investigative	5327832	C22H22ClN7O2	451.9	CC(C)(C)OC(=O)NC1=CC=C(C=C1)NC2=C3C(=NN2)N=CN=C3NC4=CC(=CC=C4)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEN1P7	1-[3-Fluoro-4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-3-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]urea	Investigative	136053657	C35H38FN5O5	627.7	COC1=CC2=C(C=CN=C2C=C1OCCCN3CCCCC3)OC4=C(C=C(C=C4)NC(=O)N/N=C/C5=CC=CC(=C5O)CC=C)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEN4C9	2-Cyano-3-[4-hydroxy-3-[[(2-carboxyphenyl)thio]methyl]-5-methoxyphenyl]propenamide	Investigative	44345336	C19H16N2O5S	384.4	COC1=CC(=CC(=C1O)CSC2=CC=CC=C2C(=O)O)/C=C(\\C#N)/C(=O)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEQ2A7	2,4-Diaminofuro[2,3-d]pyrimidine, 10	Investigative	44246327	C18H20N4O2	324.4	COC1=CC=CC=C1C(CC2=COC3=NC(=NC(=C23)N)N)C4CC4	IC50 = 56500 nM	Poor binder
T59328	Epidermal growth factor receptor	BEW72O	2-Methoxy-6-(decahydronaphthalene-1-ylidenemethyl)-1,4-benzoquinone	Investigative	11129889	C18H22O3	286.4	COC1=CC(=O)C=C(C1=O)/C=C/2\\CCCC3C2CCCC3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEXR68	Methyl 2-[(2R,3S,4S,6S)-4-[benzoyl(methyl)amino]-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-17-yl]acetate	Investigative	44352791	C38H34N4O6	642.7	C[C@]12[C@H]([C@H](C[C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CN(C6=O)CC(=O)OC)N(C)C(=O)C9=CC=CC=C9)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BEY1C5	4-[(2-Chloro-6,7-dimethoxyquinazolin-4-yl)amino]benzoic acid	Investigative	22692968	C17H14ClN3O4	359.8	COC1=C(C=C2C(=C1)C(=NC(=N2)Cl)NC3=CC=C(C=C3)C(=O)O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BF1U7Y	4-(Dimethylamino)-1-(4-phenylmethoxyphenyl)butan-1-one;hydrochloride	Investigative	45260875	C19H24ClNO2	333.8	CN(C)CCCC(=O)C1=CC=C(C=C1)OCC2=CC=CC=C2.Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BF20TO	6-Chloro-N-furan-2-ylmethyl-N'-(4-methoxy-phenyl)-[1,3,5]triazine-2,4-diamine	Investigative	694087	C15H14ClN5O2	331.76	COC1=CC=C(C=C1)NC2=NC(=NC(=N2)NCC3=CC=CO3)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BF21PJ	1-Butyl-1-(3,5-dichloro-2-hydroxybenzyl)-3-phenylturea	Investigative	46229462	C18H20Cl2N2O2	367.3	CCCCN(CC1=C(C(=CC(=C1)Cl)Cl)O)C(=O)NC2=CC=CC=C2	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BF58ES	2-(1H-Benzimidazol-2-ylmethyl)-5-pyridin-2-yl-1,3,4-oxadiazole	Investigative	137652014	C15H11N5O	277.28	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)C4=CC=CC=N4	IC50 = 73451.39 nM	Poor binder
T59328	Epidermal growth factor receptor	BF6X2P	2-(6-Amino-7H-purine-7-yl)-1-(1H-indole-3-yl)ethanone	Investigative	42604008	C15H12N6O	292.3	C1=CC=C2C(=C1)C(=CN2)C(=O)CN3C=NC4=NC=NC(=C43)N	IC50 = 82000 nM	Poor binder
T59328	Epidermal growth factor receptor	BF78CN	Indolin-2-one deriv. 9d	Investigative	5329166	C21H20N2O5	380.4	C1CCC2=C(C1)C(=C(N2)/C=C\\3/C4=C(C=CC(=C4)C(=O)O)NC3=O)CCC(=O)O	IC50 = 56500 nM	Poor binder
T59328	Epidermal growth factor receptor	BF7D5K	Benzoic acid, 4-(2,2-dicyanoethenyl)-	Investigative	5328784	C11H6N2O2	198.18	C1=CC(=CC=C1C=C(C#N)C#N)C(=O)O	Ki = 143000 nM	Poor binder
T59328	Epidermal growth factor receptor	BFCG39	N-[5-Methyl-1-[(1R,3S)-3-(prop-2-enoylamino)cyclohexyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72700165	C25H25F3N4O2	470.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)[C@@H]4CCC[C@@H](C4)NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BFE2H7	N-Phenyl-4-(pyridin-3-yl)pyrimidin-2-amine	Investigative	11311217	C15H12N4	248.28	C1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BFK2W1	(3E)-3-(Furan-2-ylmethylidene)-1H-indol-2-one	Investigative	5713379	C13H9NO2	211.22	C1=CC=C2C(=C1)/C(=C\\C3=CC=CO3)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BFP60U	2-Benzyl-5-[(6-chloro-1H-benzimidazol-2-yl)methyl]-1,3,4-oxadiazole	Investigative	137653418	C17H13ClN4O	324.8	C1=CC=C(C=C1)CC2=NN=C(O2)CC3=NC4=C(N3)C=C(C=C4)Cl	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BFQR96	3-(3,5-Dimethyl-1H-pyrrol-2-ylmethylene)-4-methyl-1,3-dihydro-indol-2-one	Investigative	10264222	C16H16N2O	252.31	CC1=C\\2C(=CC=C1)NC(=O)/C2=C\\C3=C(C=C(N3)C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BFZ50R	N-(1-(3-Bromophenylamino)-4-cyanoisoquinolin-7-yl)furan-2-carboxamide	Investigative	53319131	C21H13BrN4O2	433.3	C1=CC(=CC(=C1)Br)NC2=NC=C(C3=C2C=C(C=C3)NC(=O)C4=CC=CO4)C#N	IC50 = 55600 nM	Poor binder
T59328	Epidermal growth factor receptor	BG0I1Y	Dithiobis(1H-indole-3-carboxamide) deriv. 10j	Investigative	5328601	C34H30N4O4S2	622.8	CN1C2=C(C=C(C=C2)OC)C(=C1SSC3=C(C4=C(N3C)C=CC(=C4)OC)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BG3H5V	4-(Bis(2-chloroethyl)amino)-N-(3-morpholinopropyl)benzamide	Investigative	46207015	C18H27Cl2N3O2	388.3	C1COCCN1CCCNC(=O)C2=CC=C(C=C2)N(CCCl)CCCl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BG6PO9	Dithiobis(1H-indole-3-carboxamide) deriv. 10m	Investigative	5328604	C34H24F6N4O2S2	698.7	CN1C2=C(C=C(C=C2)C(F)(F)F)C(=C1SSC3=C(C4=C(N3C)C=CC(=C4)C(F)(F)F)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BG81EI	N-(1,3-Benzothiazol-6-yl)-8,9-dimethoxy-5,6-dihydropyrimido[4,5-b][1,4]benzothiazepin-4-amine	Investigative	44416347	C20H17N5O2S2	423.5	COC1=C(C=C2C(=C1)CNC3=C(N=CN=C3S2)NC4=CC5=C(C=C4)N=CS5)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BGAC71	Dithiobis(1H-indole-3-alkanoic acid) deriv. 30	Investigative	5328561	C26H28N2O4S2	496.6	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)CCC(=O)OC)CCC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BGE9L7	2,3-[Ethyliminobis[ethyleneoxyethylene(1H-indole-1,3-diyl)]]maleimide	Investigative	10207821	C30H32N4O4	512.6	CCN1CCOCCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCOCC1)C6=CC=CC=C65)C(=O)NC4=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BGI90S	Flavopiridol analogue 16	Investigative	5329714	C21H20ClNO5S	433.9	CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)SC4=CC=CC=C4Cl)O)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BGN38D	Chembl4204920	Investigative	145975351	C30H24FN5O4	537.5	CCCNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)C3=CC4=C(N=CC=C4)N(C3=O)C5=CC=C(C=C5)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BGR68O	N-[4-Methoxy-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide	Investigative	44273659	C23H19N5O2	397.4	COC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BH1N4K	5-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)pyridine-2-carbonitrile	Investigative	24905341	C14H13N7	279.3	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CN=C(C=C3)C#N)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BH2Q3I	5-[2-(2-Methoxyphenyl)pent-1-enyl]furo[2,3-d]pyrimidine-2,4-diamine	Investigative	52944152	C18H20N4O2	324.4	CCCC(=CC1=COC2=NC(=NC(=C12)N)N)C3=CC=CC=C3OC	IC50 = 160300 nM	Poor binder
T59328	Epidermal growth factor receptor	BH4UA1	4-N-[(4-Methoxyphenyl)methyl]pyrido[4,3-d]pyrimidine-4,7-diamine	Investigative	5328089	C15H15N5O	281.31	COC1=CC=C(C=C1)CNC2=NC=NC3=CC(=NC=C32)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BH58SY	(3Z)-2-Amino-4-(4-hydroxy-3-nitrophenyl)buta-1,3-diene-1,1,3-tricarbonitrile	Investigative	5328805	C13H7N5O3	281.23	C1=CC(=C(C=C1/C=C(\\C#N)/C(=C(C#N)C#N)N)[N+](=O)[O-])O	IC50 = 60000 nM	Poor binder
T59328	Epidermal growth factor receptor	BHL9C5	3-(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-benzoic acid ethyl ester	Investigative	10495153	C17H18N4O2	310.35	CCOC(=O)C1=CC(=CC=C1)NC2=NC=NC3=C2C(=C(N3)C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BI03EL	Indolin-2-one deriv. 4c	Investigative	5329156	C17H17N3O3S	343.4	C1CCC2=C(C1)C=C(N2)/C=C\\3/C4=C(C=CC(=C4)S(=O)(=O)N)NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BI03KG	Indolin-2-one deriv. 9e	Investigative	5329167	C21H22N2O4	366.4	COC1=CC2=C(C=C1)/C(=C/C3=C(C4=C(N3)CCCC4)CCC(=O)O)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BI0J6M	4-Chloro-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	9953676	C23H18ClN5O	415.9	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)Cl)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BI2D3Y	N-(3-Chloro-2-fluorophenyl)-8,9-dimethoxy-5,6-dihydropyrimido[4,5-b][1,4]benzothiazepin-4-amine	Investigative	44416334	C19H16ClFN4O2S	418.9	COC1=C(C=C2C(=C1)CNC3=C(N=CN=C3S2)NC4=C(C(=CC=C4)Cl)F)OC	IC50 = 62900 nM	Poor binder
T59328	Epidermal growth factor receptor	BI4JU2	6-Fluoro-3-[1-(1H-pyrrol-2-yl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one	Investigative	10728035	C13H9FN2O	228.22	C1=CNC(=C1)/C=C\\2/C3=C(C=C(C=C3)F)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BIBS58	2-[[3-(Diethoxyphosphorylmethyl)-4-hydroxyphenyl]iminomethyl]benzene-1,4-diol	Investigative	135485502	C18H22NO6P	379.3	CCOP(=O)(CC1=C(C=CC(=C1)N=CC2=C(C=CC(=C2)O)O)O)OCC	IC50 = 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	BIKM64	n-Methyl-4,5-dianilinophthalimide	Investigative	10246831	C21H17N3O2	343.4	CN1C(=O)C2=CC(=C(C=C2C1=O)NC3=CC=CC=C3)NC4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BIL2W6	4',8-Diamino-5-methoxyflavone	Investigative	10468973	C16H14N2O3	282.29	COC1=C2C(=O)C=C(OC2=C(C=C1)N)C3=CC=C(C=C3)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BILO19	2-[(5,13-Diamino-4-thia-8,10,12-triazatricyclo[7.4.0.02,6]trideca-1(13),2,5,7,9,11-hexaen-7-yl)amino]ethanol	Investigative	56935464	C11H12N6OS	276.32	C1=C2C3=C(N=CN=C3N=C(C2=C(S1)N)NCCO)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BISP89	3-(3-Chlorophenyl)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-phenyl-3,4-dihydropyrazole	Investigative	127052877	C23H19ClN2O2	390.9	C1COC2=C(O1)C=CC(=C2)C3=NN(C(C3)C4=CC(=CC=C4)Cl)C5=CC=CC=C5	IC50 = 81200 nM	Poor binder
T59328	Epidermal growth factor receptor	BIT92A	4-(1-Methyl-2-sulfanylidene-3H-indol-3-yl)butanoic acid	Investigative	5328544	C13H15NO2S	249.33	CN1C2=CC=CC=C2C(C1=S)CCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BIYQ01	Dithiobis(1H-indole-3-alkanoic acid) deriv. 37	Investigative	5328568	C28H32N2O4S2	524.7	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)CCCC(=O)OC)CCCC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJ0TN4	3-[5-(2-Carbamoyl-2-cyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-propionic acid	Investigative	44345675	C15H16N2O5S	336.4	COC1=CC(=CC(=C1O)CSCCC(=O)O)/C=C(\\C#N)/C(=O)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJ1H8L	3-(2-Chlorophenyl)-N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-4-methyl-2-oxo-1H-imidazole-5-carboxamide	Investigative	122182409	C35H36ClFN6O5	675.1	CC1=C(NC(=O)N1C2=CC=CC=C2Cl)C(=O)NC3=CC(=C(C=C3)OC4=C5C=C(C(=CC5=NC=C4)OCCCN6CCN(CC6)C)OC)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJ20EN	Cyclohexanecarboxylic acid [3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-amide	Investigative	10292737	C22H23N5O	373.5	C1CCC(CC1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJ5V8R	3-(3-Chlorophenyl)quinoline-4(1H)-one	Investigative	10538965	C15H10ClNO	255.7	C1=CC=C2C(=C1)C(=O)C(=CN2)C3=CC(=CC=C3)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJ89VY	3-Substituted indolin-2-one 16d	Investigative	5329148	C18H19N3O5S	389.4	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=CC(=C3)S(=O)(=O)N)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJ8DF1	2-(Benzylamino)-6-(2,6-dichlorophenyl)-8-methylpyrido[2,3-d]pyrimidin-7-one	Investigative	5327874	C21H16Cl2N4O	411.3	CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NCC4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJ9E6Q	2-(6-Amino-9H-purin-9-yl)-1-(pyridin-3-yl)ethanone	Investigative	42603881	C12H10N6O	254.25	C1=CC(=CN=C1)C(=O)CN2C=NC3=C(N=CN=C32)N	IC50 = 93000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJA9C4	3''-Tert-Butyl-5''-hydroxy-biphenyl-4-carboxylic acid	Investigative	10683468	C17H18O3	270.32	CC(C)(C)C1=CC(=CC(=C1)C2=CC=C(C=C2)C(=O)O)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJK14U	4-(Phenylamino)pyrazolo[3,4-d]pyrimidine deriv. 31	Investigative	5327847	C17H11Cl2N5O	372.2	C1=CC(=CC(=C1)Cl)NC2=C3C(=NN2)N=CN=C3OC4=CC(=CC=C4)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJK71W	N-[5-Methyl-1-[(1R,3R)-3-(prop-2-enoylamino)cyclohexyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	118119835	C25H25F3N4O2	470.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)[C@@H]4CCC[C@H](C4)NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJM28E	Methyl 4-(2-sulfanylidene-1,3-dihydroindol-3-yl)butanoate	Investigative	5328545	C13H15NO2S	249.33	COC(=O)CCCC1C2=CC=CC=C2NC1=S	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJR40B	5-(4-Amino-1-((piperidin-4-yl)methyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenol	Investigative	24905301	C17H19FN6O	342.4	C1CNCCC1CN2C3=NC=NC(=C3C(=N2)C4=CC(=C(C=C4)F)O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJUX64	3-(3-Chloro-phenyl)-5-hydroxy-7-methoxy-chromen-4-one	Investigative	10590515	C16H11ClO4	302.71	COC1=CC(=C2C(=C1)OC=C(C2=O)C3=CC(=CC=C3)Cl)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BJY68N	5-Naphthalen-1-ylsulfanyl-9H-pyrimido[4,5-b]indole-2,4-diamine	Investigative	137643005	C20H15N5S	357.4	C1=CC=C2C(=C1)C=CC=C2SC3=CC=CC4=C3C5=C(N=C(N=C5N4)N)N	IC50 = 167300 nM	Poor binder
T59328	Epidermal growth factor receptor	BK5DC7	2-(1H-Benzimidazol-2-ylmethyl)-5-[(2-methylphenyl)methyl]-1,3,4-oxadiazole	Investigative	137654543	C18H16N4O	304.3	CC1=CC=CC=C1CC2=NN=C(O2)CC3=NC4=CC=CC=C4N3	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BK5V1Q	4',8-Diamino-7-hydroxyflavone	Investigative	10423146	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3)O)N)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BK82PR	[2-(3-Benzoyl-1-methyl-1H-indol-2-yldisulfanyl)-1-methyl-1H-indol-3-yl]-phenyl-methanone	Investigative	11756855	C32H24N2O2S2	532.7	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)C5=CC=CC=C5)C(=O)C6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BK93CY	1,2-Benzenedicarboxylic acid, 4,5-bis(phenylamino)-, dimethyl ester	Investigative	10407176	C22H20N2O4	376.4	COC(=O)C1=CC(=C(C=C1C(=O)OC)NC2=CC=CC=C2)NC3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BK9ZA6	4-[[5,21-Dihydroxy-12,14-dioxo-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaen-13-yl]amino]benzoic acid	Investigative	44273618	C33H26N4O11	654.6	C1=CC2=C(C(=C1)O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC6=CC=C(C=C6)C(=O)O)C7=C(N4C8C(C(C(C(O8)CO)O)O)O)C(=CC=C7)O	IC50 = 90000 nM	Poor binder
T59328	Epidermal growth factor receptor	BKBF97	Malonoben	Investigative	5614	C18H22N2O	282.4	CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C(C#N)C#N	Ki = 155000 nM	Poor binder
T59328	Epidermal growth factor receptor	BKET50	Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26f	Investigative	5329234	C19H13ClFN5O3	413.8	CC1=C(NC(=C1)C(=O)O)/C=C\\2/C3=C(NC2=O)N=CN=C3NC4=CC(=C(C=C4)F)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BKFV04	4-N-(3-Bromophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-4-N-methyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	46912446	C22H22BrN5O2	468.3	CN(C1=CC(=CC=C1)Br)C2=NC(=NC3=C2C=C(N3)CC4=C(C=CC(=C4)OC)OC)N	IC50 = 143500 nM	Poor binder
T59328	Epidermal growth factor receptor	BKGE82	1 H-Indole-3-alkanamide deriv. 10m	Investigative	5328581	C40H38N4O8S2	766.9	COC(=O)C1=C(C=C(C=C1)CNC(=O)CCC2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)CCC(=O)NCC6=CC(=C(C=C6)C(=O)OC)O)O	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BKQ9H7	N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[5-methyl-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide	Investigative	86677253	C29H35N7O2	513.6	CC1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC	IC50 = 71000 nM	Poor binder
T59328	Epidermal growth factor receptor	BKV54S	N-1H-Indol-5-yl-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	Investigative	46887397	C22H19N5	353.4	C1=CC=C(C=C1)CCC2=CC3=C(N2)N=CN=C3NC4=CC5=C(C=C4)NC=C5	IC50 = 56100 nM	Poor binder
T59328	Epidermal growth factor receptor	BKWV73	1-[2-[5-(1H-Benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]phenyl]ethanone	Investigative	137633488	C18H14N4O2	318.3	CC(=O)C1=CC=CC=C1C2=NN=C(O2)CC3=NC4=CC=CC=C4N3	IC50 = 65400 nM	Poor binder
T59328	Epidermal growth factor receptor	BL0HG7	N-[5-Methyl-1-[(1R,2R)-2-(prop-2-enoylamino)cyclohexyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72700079	C25H25F3N4O2	470.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)[C@@H]4CCCC[C@H]4NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BL3J7V	3-(3,5-Dimethyl-1H-pyrrol-2-ylmethylene)-5-methyl-1,3-dihydro-indol-2-one	Investigative	10562777	C16H16N2O	252.31	CC1=CC\\2=C(C=C1)NC(=O)/C2=C\\C3=C(C=C(N3)C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BL4HV3	4-[(4-Amino-6-cyanopyrido[2,3-d]pyrimidin-7-yl)amino]benzenesulfonamide	Investigative	56649645	C14H11N7O2S	341.35	C1=CC(=CC=C1NC2=NC3=NC=NC(=C3C=C2C#N)N)S(=O)(=O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BL4S1F	Methyl 2,3-dihydro-2-thioxo-1H-indole-3-propanoate	Investigative	5328541	C12H13NO2S	235.3	COC(=O)CCC1C2=CC=CC=C2NC1=S	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BL97TX	3-Substituted indolin-2-one 11h	Investigative	5329145	C24H22N2O4	402.4	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=C(C=C(C=C3)C4=CC=C(C=C4)OC)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BL98OJ	2-Aminopyrido[2,3-d]pyrimidin-7(8H)-one 19	Investigative	5327866	C15H11Cl2N3O	320.2	CC1=NC=C2C=C(C(=O)N(C2=N1)C)C3=C(C=CC=C3Cl)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BL9GC2	4-(Bis(2-chloroethyl)amino)-N-dodecylbenzamide	Investigative	46207037	C23H38Cl2N2O	429.5	CCCCCCCCCCCCNC(=O)C1=CC=C(C=C1)N(CCCl)CCCl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLB38M	3-[1-(4-Bromo-phenyl)-meth-(Z)-ylidene]-1-methyl-1,3-dihydro-indol-2-one	Investigative	5427224	C16H12BrNO	314.18	CN1C2=CC=CC=C2/C(=C/C3=CC=C(C=C3)Br)/C1=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLB49J	4-[[6-Amino-4-butoxy-5-(2,6-difluorobenzoyl)pyridin-2-yl]amino]benzenesulfonamide	Investigative	5330847	C22H22F2N4O4S	476.5	CCCCOC1=CC(=NC(=C1C(=O)C2=C(C=CC=C2F)F)N)NC3=CC=C(C=C3)S(=O)(=O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLF03M	Indolin-2-one deriv. 4g	Investigative	5329160	C24H22N2O2	370.4	COC1=CC=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=CC5=C(N4)CCCC5)/C(=O)N3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLJO35	Dithiobis(1H-indole-3-carboxamide) deriv. 10u	Investigative	5328612	C32H24Cl2N4O2S2	631.6	CN1C2=C(C=CC=C2Cl)C(=C1SSC3=C(C4=C(N3C)C(=CC=C4)Cl)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLKN89	3-((4,5,6,7-Tetrahydro-1H-indol-2-yl)methylene)indolin-2-one	Investigative	5329154	C17H16N2O	264.32	C1CCC2=C(C1)C=C(N2)/C=C\\3/C4=CC=CC=C4NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLN69O	3-Acyl-2,6-diaminopyridine deriv. 2p	Investigative	5330830	C20H18F2N4O3S	432.4	CN(C)S(=O)(=O)C1=CC=C(C=C1)NC2=NC(=C(C=C2)C(=O)C3=C(C=CC=C3F)F)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLT58Y	3-Substituted indolin-2-one 11d	Investigative	5329141	C18H18N2O4	326.3	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=C(C=C(C=C3)OC)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BLY3P8	2-(Cyclohexylamino)-6-(2,6-dichlorophenyl)-8-methylpyrido[2,3-d]pyrimidin-7-one	Investigative	5327872	C20H20Cl2N4O	403.3	CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4CCCCC4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BM3W2U	2-(6-Amino-9H-purine-9-yl)-1-phenylethanone	Investigative	12814948	C13H11N5O	253.26	C1=CC=C(C=C1)C(=O)CN2C=NC3=C(N=CN=C32)N	IC50 = 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	BM59RL	3-[1-(4-Chloro-1H-pyrazol-3-yl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one	Investigative	135536640	C12H8ClN3O	245.66	C1=CC=C2C(=C1)/C(=C/C3=C(C=NN3)Cl)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BM5O1B	N',N'-Dimethyl-N-(5H-pyrimido[5,4-b]indol-4-yl)ethane-1,2-diamine;hydrochloride	Investigative	45262457	C14H18ClN5	291.78	CN(C)CCNC1=NC=NC2=C1NC3=CC=CC=C32.Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMBE82	4-[Phenyl(acetyl)amino]-5-anilinophthalimide	Investigative	10361853	C22H17N3O3	371.4	CC(=O)N(C1=CC=CC=C1)C2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMBP07	4-[2-Oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-benzoic acid	Investigative	2365265	C16H11NO3	265.26	C1=CC=C2C(=C1)/C(=C/C3=CC=C(C=C3)C(=O)O)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMEJ76	(3Z)-2-Amino-4-(1H-indol-5-yl)buta-1,3-diene-1,1,3-tricarbonitrile	Investigative	5328748	C15H9N5	259.269	C1=CC2=C(C=CN2)C=C1/C=C(\\C#N)/C(=C(C#N)C#N)N	IC50 ~ 60000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMG7W8	N-[5-Methyl-1-[4-(prop-2-enoylamino)phenyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72699658	C25H19F3N4O2	464.4	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4=CC=C(C=C4)NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMHZ45	4',8-Diaminoflavone	Investigative	10264200	C15H12N2O2	252.27	C1=CC2=C(C(=C1)N)OC(=CC2=O)C3=CC=C(C=C3)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMJ24B	5-Chloro-4-N-(3-methoxyphenyl)-9H-pyrimido[4,5-b]indole-2,4-diamine	Investigative	54673975	C17H14ClN5O	339.8	COC1=CC=CC(=C1)NC2=NC(=NC3=C2C4=C(N3)C=CC=C4Cl)N	IC50 = 82900 nM	Poor binder
T59328	Epidermal growth factor receptor	BMO0H5	6-Chloro-N-(4-methylsulfonylphenyl)-[1,3]dioxolo[4,5-g]quinazolin-8-amine	Investigative	76313719	C16H12ClN3O4S	377.8	CS(=O)(=O)C1=CC=C(C=C1)NC2=NC(=NC3=CC4=C(C=C32)OCO4)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMQ6C9	Dithiobis(1H-indole-3-carboxamide) deriv. 10n	Investigative	5328605	C34H24N6O2S2	612.7	CN1C2=C(C=C(C=C2)C#N)C(=C1SSC3=C(C4=C(N3C)C=CC(=C4)C#N)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 = 54100 nM	Poor binder
T59328	Epidermal growth factor receptor	BMWF10	(3-Chloro-phenyl)-(2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine	Investigative	13498036	C15H15ClN4	286.76	CC1=C(NC2=C1C(=NC(=N2)C)NC3=CC(=CC=C3)Cl)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMY0V9	4-[(6-Chloro-[1,3]dioxolo[4,5-g]quinazolin-8-yl)amino]-N-(1,3-thiazol-2-yl)benzenesulfonamide	Investigative	76328168	C18H12ClN5O4S2	461.9	C1OC2=C(O1)C=C3C(=C2)C(=NC(=N3)Cl)NC4=CC=C(C=C4)S(=O)(=O)NC5=NC=CS5	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BMYE30	2-[(5-Hydroxy-2-nitrophenyl)methylidene]propanedinitrile	Investigative	5328786	C10H5N3O3	215.16	C1=CC(=C(C=C1O)C=C(C#N)C#N)[N+](=O)[O-]	IC50 = 96000 nM	Poor binder
T59328	Epidermal growth factor receptor	BN0E9S	4-N-(4-Chloro-2-fluorophenyl)-6-[(2-methylphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	56951304	C20H17ClFN5	381.8	CC1=CC=CC=C1CC2=CC3=C(N2)N=C(N=C3NC4=C(C=C(C=C4)Cl)F)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BN3Y0E	3-[[5-Cyano-6-(cyclopentylamino)pyrimidin-4-yl]amino]-4-methyl-N-(1,2-oxazol-3-yl)benzamide	Investigative	11235063	C21H21N7O2	403.4	CC1=C(C=C(C=C1)C(=O)NC2=NOC=C2)NC3=C(C(=NC=N3)NC4CCCC4)C#N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BN47UZ	3-[1-(3,4-Dimethyl-1H-pyrrol-2-yl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one	Investigative	10236164	C15H14N2O	238.28	CC1=CNC(=C1C)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BNF30J	1-Butyl-1-(2-hydroxy-3,5-dimethylbenzyl)-3-phenylthiourea	Investigative	46229567	C23H24N2OS	376.5	CC1=CC(=C(C(=C1)CN(CC2=CC=CC=C2)C(=S)NC3=CC=CC=C3)O)C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BNLS21	4',8-Diamino-5-hydroxyflavone	Investigative	10355659	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(C=CC(=C3O2)N)O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BNO1C9	3-[3-(5-Chloro-benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide	Investigative	44345396	C19H14ClN3O3S2	431.9	COC1=CC(=CC(=C1O)CSC2=NC3=C(S2)C=CC(=C3)Cl)/C=C(\\C#N)/C(=O)N	IC50 ~ 83000 nM	Poor binder
T59328	Epidermal growth factor receptor	BNPQ90	Diselenobis(1H-indole) deriv. 21	Investigative	5328098	C28H32N2O4Se2	618.5	CC(C)(C)OC(=O)C1=C(N(C2=CC=CC=C21)C)[Se][Se]C3=C(C4=CC=CC=C4N3C)C(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BNQJ48	N-Cyclohexyl-5H-pyrimido[5,4-b]indol-4-amine	Investigative	5328389	C16H18N4	266.34	C1CCC(CC1)NC2=NC=NC3=C2NC4=CC=CC=C43	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BNU6H8	Chembl4285414	Investigative	145992844	C21H15BrFN5O2	468.3	C1=CC(=CC=C1/C=N/NC(=O)NC2=CC(=C(C=C2)OC3=C4C=CNC4=NC=C3)F)Br	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BNUV73	3-(2-Chloroquinolin-6-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905216	C17H15ClN6	338.8	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)N=C(C=C4)Cl)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BO1VJ7	3-[[2-[3-Methyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide	Investigative	134130554	C22H27N7O2S	453.6	CC1=C(C=CC(=C1)NC2=NC=CC(=N2)NC3=CC(=CC=C3)S(=O)(=O)N)N4CCN(CC4)C	IC50 ~ 150000 nM	Poor binder
T59328	Epidermal growth factor receptor	BO25WR	N-[3-(4-Pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-isonicotinamide	Investigative	11474111	C21H16N6O	368.4	C1=CC(=CC(=C1)NC(=O)C2=CC=NC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BO34ZN	1-Ethyl-2-[[1-ethyl-3-(phenylcarbamoyl)indol-2-yl]disulfanyl]-N-phenylindole-3-carboxamide	Investigative	10483554	C34H30N4O2S2	590.8	CCN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3CC)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BO5R7P	3-(5-Ethyl-furan-2-ylmethylene)-1,3-dihydro-indol-2-one	Investigative	10537949	C15H13NO2	239.27	CCC1=CC=C(O1)/C=C/2\\C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BOA45D	3-(4-Ethoxy-3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905292	C14H15N5O2	285.3	CCOC1=C(C=C(C=C1)C2=C3C(=NC=NC3=NN2)N)OC	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BOD34M	N-(4-Bromophenyl)-8,9-dimethoxy-5,6-dihydropyrimido[4,5-b][1,4]benzoxazepin-4-amine	Investigative	44416693	C19H17BrN4O3	429.3	COC1=C(C=C2C(=C1)CNC3=C(N=CN=C3O2)NC4=CC=C(C=C4)Br)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BOHV12	4-N-(3-Bromo-4-fluorophenyl)-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	71525245	C19H16BrFN6	427.3	C1=CC=NC(=C1)CCC2=CC3=C(N2)N=C(N=C3NC4=CC(=C(C=C4)F)Br)N	IC50 = 85900 nM	Poor binder
T59328	Epidermal growth factor receptor	BOI10J	5,6-Bis-(biphenyl-4-ylamino)-isoindole-1,3-dione	Investigative	10345125	C32H23N3O2	481.5	C1=CC=C(C=C1)C2=CC=C(C=C2)NC3=C(C=C4C(=C3)C(=O)NC4=O)NC5=CC=C(C=C5)C6=CC=CC=C6	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BOI90M	4-Hydroxybenzylidenemalononitrile	Investigative	92970	C10H6N2O	170.17	C1=CC(=CC=C1C=C(C#N)C#N)O	Ki = 160000 nM	Poor binder
T59328	Epidermal growth factor receptor	BON75J	4-(3-Chloro-phenylamino)-3-(3-nitro-phenyl)-1H-pyrazolo[3,4-d]pyrimidine	Investigative	5327843	C17H11ClN6O2	366.8	C1=CC(=CC(=C1)[N+](=O)[O-])C2=C3C(=NN2)N=CN=C3NC4=CC(=CC=C4)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BOT8V6	Methyl-phenyl-(2,6,7-trimethoxy-quinazolin-4-yl)-amine	Investigative	44355543	C18H19N3O3	325.4	CN(C1=CC=CC=C1)C2=NC(=NC3=CC(=C(C=C32)OC)OC)OC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BP05LG	Cc1ccc2n(C3CN(C3)C(=O)C=C)c(NC(=O)c3cccc(c3)C(F)(F)F)nc2c1	Investigative	118223929	C22H19F3N4O2	428.4	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4CN(C4)C(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BP28SX	5-(4-Amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenol	Investigative	24905286	C12H11N5O2	257.25	COC1=C(C=C(C=C1)C2=C3C(=NC=NC3=NN2)N)O	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BP2WY4	2-(2-Amino-ethyl-amino)-6-(3-chloro-phenylamino)-9-ethyl-9H-purine	Investigative	9949448	C15H18ClN7	331.8	CCN1C=NC2=C(N=C(N=C21)NCCN)NC3=CC(=CC=C3)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BP3VD9	N4-(4-Fluoro-3-(trifluoromethyl)phenyl)-6-phenethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	25022735	C21H17F4N5	415.4	C1=CC=C(C=C1)CCC2=CC3=C(N2)N=C(N=C3NC4=CC(=C(C=C4)F)C(F)(F)F)N	IC50 = 122000 nM	Poor binder
T59328	Epidermal growth factor receptor	BP57ZB	N-[4-(4,5-Dichloro-2-fluoro-phenylamino)-quinazolin-6-yl]-2-methoxy-acetamide	Investigative	10385997	C17H13Cl2FN4O2	395.2	COCC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3F)Cl)Cl	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BP59ER	N-(4-Chloro-3-methylphenyl)-8,9-dimethoxy-2-methyl-5,6-dihydropyrimido[4,5-b][1,4]benzothiazepin-4-amine	Investigative	11690494	C21H21ClN4O2S	428.9	CC1=C(C=CC(=C1)NC2=C3C(=NC(=N2)C)SC4=CC(=C(C=C4CN3)OC)OC)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BP79LE	2-Propenamide, N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-2-pyrimidinyl)amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-	Investigative	101884762	C26H29ClN8O2	521	CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=C(C(=N2)C3=C4C=CC=CN4N=C3)Cl)OC	IC50 = 145000 nM	Poor binder
T59328	Epidermal growth factor receptor	BPA5J6	N-(5-{[5-Chloro-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}-2-{2-dimethylaminoethyl-methylamino}-4-methoxyphenyl)prop-2-enamide	Investigative	86677265	C28H32ClN7O2	534.1	CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3Cl)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC	IC50 = 58000 nM	Poor binder
T59328	Epidermal growth factor receptor	BPCA13	4,5-Bis-(4-methoxyanilino)phthalimide	Investigative	10318148	C22H19N3O4	389.4	COC1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)OC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BPI4B9	3-Substituted indolin-2-one 16e	Investigative	5329149	C19H20N2O4	340.4	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=C(C=C3)OC)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BPJ6U0	N-(3-Bromophenyl)-8,9-dimethoxy-2-methyl-5,6-dihydropyrimido[4,5-b][1,4]benzoxazepin-4-amine	Investigative	44416569	C20H19BrN4O3	443.3	CC1=NC(=C2C(=N1)OC3=CC(=C(C=C3CN2)OC)OC)NC4=CC(=CC=C4)Br	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BPLJ98	(3Z)-3-[[4-(Dimethylamino)phenyl]methylidene]-6-fluoro-1H-indol-2-one	Investigative	44321717	C17H15FN2O	282.31	CN(C)C1=CC=C(C=C1)/C=C\\2/C3=C(C=C(C=C3)F)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BPV4H6	2-(6-((R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy)quinolin-3-yl)cyclopropanecarboxamide	Investigative	46232556	C21H17Cl2FN2O2	419.3	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=CC(=CN=C3C=C2)C4CC4C(=O)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BPYO17	13-(2,3-Dihydroxypropylamino)-5,21-dihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione	Investigative	44273647	C29H28N4O11	608.6	C1=CC2=C(C(=C1)O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NCC(CO)O)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C(=CC=C6)O	IC50 = 180000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ15CD	N-{4-Methyl-3-[4-(1-oxy-pyridin-3-yl)-pyrimidin-2-ylamino]-phenyl}-benzamide	Investigative	44273555	C23H19N5O2	397.4	CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=C[N+](=CC=C4)[O-]	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ1Y4B	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-m-tolyl-amine	Investigative	10848423	C15H16N4	252.31	CC1=CC(=CC=C1)NC2=NC=NC3=C2C(=C(N3)C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ37SK	3-Substituted indolin-2-one 16c	Investigative	5329147	C19H18N2O5	354.4	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=CC(=C3)C(=O)O)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ4L3I	Malononitrile, (5-nitrovanillylidene)-	Investigative	58857	C11H7N3O4	245.19	COC1=CC(=CC(=C1O)[N+](=O)[O-])C=C(C#N)C#N	Ki = 55000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ4YP0	Methyl 3-[4-methyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoate	Investigative	10215023	C18H18N2O3	310.3	CC1=C(NC=C1CCC(=O)OC)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ5E2O	4-(3,4-Dimethoxy-phenylsulfanyl)-6,7-dimethoxy-quinazoline	Investigative	44355456	C18H18N2O4S	358.4	COC1=C(C=C(C=C1)SC2=NC=NC3=CC(=C(C=C32)OC)OC)OC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ5GN3	7-((1H-Imidazol-1-yl)methyl)-3-(thiophen-3-yl)-1,4-dihydroindeno[1,2-c]pyrazole	Investigative	44414322	C18H14N4S	318.4	C1C2=C(C=C(C=C2)CN3C=CN=C3)C4=C1C(=NN4)C5=CSC=C5	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQ8W7Y	4-[5-(1H-Benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]phenol	Investigative	137636527	C16H12N4O2	292.29	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)C4=CC=C(C=C4)O	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQE4L1	7-Aminopyrido[4,3-d]pyrimidine 8q	Investigative	5328093	C16H18N6	294.35	CN(C)C1=CC=CC=C1CNC2=NC=NC3=CC(=NC=C32)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQK70P	3-Substituted indolin-2-one 11b	Investigative	5329139	C18H16N2O5	340.3	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=C(C=CC(=C3)C(=O)O)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQN3U7	8-(Benzylamino)-1-(3-morpholin-4-ylpropyl)-[1,3]oxazolo[4,5-g]quinazolin-2-one	Investigative	70682364	C23H25N5O3	419.5	C1COCCN1CCCN2C3=C(C=C4C(=C3)C(=NC=N4)NCC5=CC=CC=C5)OC2=O	IC50 = 65000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQR45E	2-[5-(1H-Benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]benzoic acid	Investigative	137641315	C17H12N4O3	320.3	C1=CC=C(C(=C1)C2=NN=C(O2)CC3=NC4=CC=CC=C4N3)C(=O)O	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQR7V3	N-[4-(2,4-Dimethoxyanilino)quinazoline-6-yl]acrylamide	Investigative	76329348	C19H18N4O3	350.4	COC1=CC(=C(C=C1)NC2=NC=NC3=C2C=C(C=C3)NC(=O)C=C)OC	IC50 = 53600 nM	Poor binder
T59328	Epidermal growth factor receptor	BQV2S3	(E)-2-Cyano-N-[4-[[4-[[(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]cyclohexyl]methyl]cyclohexyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide	Investigative	5467485	C33H36N4O6	584.7	C1C(CCC(C1)NC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N)CC3CCC(CC3)NC(=O)/C(=C/C4=CC(=C(C=C4)O)O)/C#N	IC50 ~ 83000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQW0B2	(3Z)-3-[(5-Methylsulfanylthiophen-2-yl)methylidene]-1H-indol-2-one	Investigative	10636005	C14H11NOS2	273.4	CSC1=CC=C(S1)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQW81G	(3Z)-3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylidene]-6-fluoro-1H-indol-2-one	Investigative	10753550	C15H13FN2O	256.269	CC1=CC(=C(N1)/C=C\\2/C3=C(C=C(C=C3)F)NC2=O)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQX48C	5-[(1e)-2-(2-Methoxyphenyl)prop-1-En-1-Yl]furo[2,3-D]pyrimidine-2,4-Diamine	Investigative	6477203	C16H16N4O2	296.32	C/C(=C\\C1=COC2=NC(=NC(=C12)N)N)/C3=CC=CC=C3OC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQX9A6	N-Cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-yl)methylamino)benzamide	Investigative	11632737	C19H17F2N5OS	401.4	C1CC1NC(=O)C2=CC(=C(C=C2F)F)NCC3=CN=C(S3)NC4=CC=CC=N4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BQYJ56	N-Benzyl-2-(2-sulfanylidene-1,3-dihydroindol-3-yl)acetamide	Investigative	5328589	C17H16N2OS	296.4	C1=CC=C(C=C1)CNC(=O)CC2C3=CC=CC=C3NC2=S	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BR29GL	N-[4-(3-Iodo-phenylamino)-quinazolin-6-yl]-2-methoxy-acetamide	Investigative	9980337	C17H15IN4O2	434.23	COCC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)I	IC50 = 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BR2EP3	4-[(2-Chloro-6,7-dimethoxyquinazolin-4-yl)amino]-N,N-dimethylbenzenesulfonamide	Investigative	76335418	C18H19ClN4O4S	422.9	CN(C)S(=O)(=O)C1=CC=C(C=C1)NC2=NC(=NC3=CC(=C(C=C32)OC)OC)Cl	IC50 = 67200 nM	Poor binder
T59328	Epidermal growth factor receptor	BR4X5J	(3-Nitro-phenyl)-(4-pyridin-4-yl-pyrimidin-2-yl)-amine	Investigative	9814609	C15H11N5O2	293.28	C1=CC(=CC(=C1)[N+](=O)[O-])NC2=NC=CC(=N2)C3=CC=NC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BR5XO0	7,8-Dihydroxyisoquinoline-3-carboxamide	Investigative	135468746	C10H8N2O3	204.18	C1=CC(=C(C2=CN=C(C=C21)C(=O)N)O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BR7GT9	N'-(4-Chlorophenyl)-5-chloro-9H-pyrimido[4,5-b]indole-2,4-diamine	Investigative	71583527	C16H11Cl2N5	344.2	C1=CC2=C(C(=C1)Cl)C3=C(N2)N=C(N=C3NC4=CC=C(C=C4)Cl)N	IC50 = 63600 nM	Poor binder
T59328	Epidermal growth factor receptor	BR7Q4U	5-[[3-Fluoro-4-[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]iminomethyl]-6-hydroxy-1-(4-methylphenyl)pyrimidine-2,4-dione	Investigative	136215817	C35H34FN5O6	639.7	CC1=CC=C(C=C1)N2C(=C(C(=O)NC2=O)C=NC3=CC(=C(C=C3)OC4=C5C=C(C(=CC5=NC=C4)OCCCN6CCCC6)OC)F)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRB60P	4-N-[2-(Dimethylamino)phenyl]pyrido[4,3-d]pyrimidine-4,7-diamine	Investigative	5328066	C15H16N6	280.33	CN(C)C1=CC=CC=C1NC2=NC=NC3=CC(=NC=C32)N	IC50 = 69000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRBF08	Lavendustin c	Investigative	3896	C14H13NO5	275.26	C1=CC(=C(C=C1NCC2=C(C=CC(=C2)O)O)C(=O)O)O	IC50 = 92000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRE48N	4,5-Bis[4-iodoanilino]phthalimide	Investigative	10325906	C20H13I2N3O2	581.1	C1=CC(=CC=C1NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)I)I	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRF9C1	1,3N-Dimethyl-3N-phenyl-2-[1-methyl-3-methyl(phenyl)carbamoyl-1H-2-indolyldisulfanyl]-1H-3-indolecarboxamide	Investigative	9985870	C34H30N4O2S2	590.8	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)N(C)C5=CC=CC=C5)C(=O)N(C)C6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRN7B6	Indolin-2-one deriv. 9i	Investigative	5329171	C27H26N2O4	442.5	COC1=CC=C(C=C1)C2=CC3=C(C=C2)/C(=C/C4=C(C5=C(N4)CCCC5)CCC(=O)O)/C(=O)N3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRP6V7	4-[[6-Amino-5-(2,6-difluorobenzoyl)pyridin-2-yl]amino]benzenesulfonamide	Investigative	5330832	C18H14F2N4O3S	404.4	C1=CC(=C(C(=C1)F)C(=O)C2=C(N=C(C=C2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRT30C	N-[(2R,3S,4S,6S)-3-Methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methyl-3,5-dinitrobenzamide	Investigative	44352845	C35H28N6O8	660.6	C[C@]12[C@H]([C@H](C[C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC(=CC(=C9)[N+](=O)[O-])[N+](=O)[O-])OC	IC50 ~ 70000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRV54M	Dithiobis(1H-indole-3-carboxamide) deriv. 10b	Investigative	5328593	C32H24Cl2N4O2S2	631.6	CN1C2=C(C(=CC=C2)Cl)C(=C1SSC3=C(C4=C(N3C)C=CC=C4Cl)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BRWP09	3',6-Diaminoflavone	Investigative	10264201	C15H12N2O2	252.27	C1=CC(=CC(=C1)N)C2=CC(=O)C3=C(O2)C=CC(=C3)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BS0W1X	6-[(2,4-Dichlorophenyl)methyl]-4-N-(3-ethynylphenyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	46886973	C21H15Cl2N5	408.3	C#CC1=CC(=CC=C1)NC2=NC(=NC3=C2C=C(N3)CC4=C(C=C(C=C4)Cl)Cl)N	IC50 = 55200 nM	Poor binder
T59328	Epidermal growth factor receptor	BS7W3G	3-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-benzenesulfonamide	Investigative	24905162	C14H16N6O2S	332.38	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC(=CC=C3)S(=O)(=O)N)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BSC9A5	5-Chloro-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one	Investigative	10562306	C13H9ClN2O	244.67	C1=CNC(=C1)/C=C\\2/C3=C(C=CC(=C3)Cl)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BSE49J	4-Formyl-alpha-cyanocinnamic acid	Investigative	5328792	C11H7NO3	201.18	C1=CC(=CC=C1/C=C(\\C#N)/C(=O)O)C=O	Ki = 140000 nM	Poor binder
T59328	Epidermal growth factor receptor	BSR32G	(3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-(1H-imidazol-2-ylmethylidene)-2,3-dihydro-1H-indol-2-one	Investigative	135678111	C19H15N3O3	333.3	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=NC=CN4)/C(=O)N3)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BSU24W	2-[3-Fluoro-4-[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-N-[(E)-[4-(trifluoromethyl)phenyl]methylideneamino]acetamide	Investigative	118715995	C33H32F4N4O4	624.6	COC1=CC2=C(C=CN=C2C=C1OCCCN3CCCC3)OC4=C(C=C(C=C4)CC(=O)N/N=C/C5=CC=C(C=C5)C(F)(F)F)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BSW2G3	3-Substituted indolin-2-one 11f	Investigative	5329143	C24H22N2O4	402.4	CC1=C(NC=C1CCC(=O)O)/C=C\\2/C3=C(C=C(C=C3)C4=CC(=CC=C4)OC)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BSX6A0	5-Benzyl-4-methyl-2-[(3-naphthalen-2-yloxy-2-oxopropyl)amino]thiophene-3-carboxamide	Investigative	57398558	C26H24N2O3S	444.5	CC1=C(SC(=C1C(=O)N)NCC(=O)COC2=CC3=CC=CC=C3C=C2)CC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BT07UQ	3-Substituted indolin-2-one 9b	Investigative	5329135	C17H15BrN2O3	375.2	CC1=CNC(=C1CCC(=O)O)/C=C\\2/C3=C(C=CC(=C3)Br)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BT1HK6	1-Butyl-1-(3,5-dibromo-2-hydroxybenzyl)-3-phenylurea	Investigative	46229463	C18H20Br2N2O2	456.2	CCCCN(CC1=C(C(=CC(=C1)Br)Br)O)C(=O)NC2=CC=CC=C2	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BT2E5U	Methyl 3,10-dioxo-20-propoxy-12-oxapentacyclo[11.8.0.02,11.04,9.014,19]henicosa-1(13),2(11),4,6,8,14,16,18,20-nonaene-21-carboxylate	Investigative	44407248	C25H18O6	414.4	CCCOC1=C(C2=C(C3=CC=CC=C31)OC4=C2C(=O)C5=CC=CC=C5C4=O)C(=O)OC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BT31KV	(2-Chloro-6,7-dimethoxy-quinazolin-4-yl)-methyl-phenyl-amine	Investigative	22692676	C17H16ClN3O2	329.8	CN(C1=CC=CC=C1)C2=NC(=NC3=CC(=C(C=C32)OC)OC)Cl	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BT45WY	4-Methyl-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	9822042	C24H21N5O	395.5	CC1=CC=C(C=C1)C(=O)NC2=CC(=C(C=C2)C)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BT4GI9	1 H-Indole-3-alkanamide deriv. 10p	Investigative	5328584	C40H40N6O4S2	732.9	CC(=O)NC(CC1=C(NC2=CC=CC=C21)SSC3=C(C4=CC=CC=C4N3)CC(C(=O)NCC5=CC=CC=C5)NC(=O)C)C(=O)NCC6=CC=CC=C6	IC50 = 51000 nM	Poor binder
T59328	Epidermal growth factor receptor	BT90IG	Schembl22498984	Investigative	137645121	C15H11N5O	277.28	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)C4=CN=CC=C4	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTCD52	3-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzonitrile	Investigative	24905160	C15H14N6	278.31	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC=CC(=C3)C#N)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTD49O	Benzylidenemalononitrile (BMN) deriv. 65	Investigative	5328812	C10H7NO4	205.17	C1=CC(=C(C=C1O)/C=C(/C#N)\\C(=O)O)O	IC50 = 75000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTF2Y1	4',6,8-Triaminoflavone	Investigative	10038606	C15H13N3O2	267.28	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=CC(=C3)N)N)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTH2P8	4-Amino-2,7-bis(2-hydroxyethylamino)pyrido[2,3-d]pyrimidine-6-carbonitrile	Investigative	56935468	C12H15N7O2	289.29	C1=C(C(=NC2=NC(=NC(=C21)N)NCCO)NCCO)C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTH68Q	1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea	Investigative	6539985	C20H17N5OS	375.4	CC1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=CSC4=NC=NC(=C34)N	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTIG04	4-N-(3-Chloro-4-fluorophenyl)-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	71525246	C19H16ClFN6	382.8	C1=CC=NC(=C1)CCC2=CC3=C(N2)N=C(N=C3NC4=CC(=C(C=C4)F)Cl)N	IC50 = 110600 nM	Poor binder
T59328	Epidermal growth factor receptor	BTMH85	Indolin-2-one deriv. 9a	Investigative	5329163	C20H20N2O3	336.4	C1CCC2=C(C1)C(=C(N2)/C=C\\3/C4=CC=CC=C4NC3=O)CCC(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTMW67	6,7-Dihydroxyisoquinoline-3-carboxamide	Investigative	135484881	C10H8N2O3	204.18	C1=C2C=C(N=CC2=CC(=C1O)O)C(=O)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTQK89	3-[1-(4-Pyrrolidin-1-yl-phenyl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one	Investigative	5427216	C19H18N2O	290.4	C1CCN(C1)C2=CC=C(C=C2)/C=C\\3/C4=CC=CC=C4NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BTV10B	3-Substituted indolin-2-one 16b	Investigative	5329146	C18H17BrN2O3	389.2	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=CC(=C3)Br)NC2=O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BU3B6P	Indolin-2-one deriv. 4e	Investigative	5329158	C18H18N2O2	294.3	COC1=CC2=C(C=C1)/C(=C/C3=CC4=C(N3)CCCC4)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BU3CK2	Tert-Butyl-2-{5-(4-hydroxyphenethoxy)-1-{5-[4-(methylthio)phenyl]pentyl}-1H-indole-3-yl}ethyl carbamate	Investigative	46888666	C35H44N2O4S	588.8	CC(C)(C)OC(=O)NCCC1=CN(C2=C1C=C(C=C2)OCCC3=CC=C(C=C3)O)CCCCCC4=CC=C(C=C4)SC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BU5E9W	(3Z)-3-[(1-Methylpyrrol-2-yl)methylidene]-1H-indol-2-one	Investigative	6536705	C14H12N2O	224.26	CN1C=CC=C1/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BU61KZ	Dimeric Tyrphostin 21	Investigative	5329269	C27H22N6O2	462.5	C1=CC2=C(C=C1/C=C(/C(=O)NCCCNC(=O)/C(=C/C3=CC4=C(NC=C4)C=C3)/C#N)\\C#N)C=CN2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BUD4J7	N-[4-Methyl-3-(4-thiophen-2-yl-pyrimidin-2-ylamino)-phenyl]-benzamide	Investigative	44273554	C22H18N4OS	386.5	CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=CC=CS4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BUPG71	4-N-(4-Chloro-2-fluorophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine	Investigative	57395925	C21H19ClFN5O2	427.9	COC1=CC(=C(C=C1)OC)CC2=CC3=C(N2)N=C(N=C3NC4=C(C=C(C=C4)Cl)F)N	IC50 = 112700 nM	Poor binder
T59328	Epidermal growth factor receptor	BUWN34	2-(4-p-Tolyl-1H-1,2,3-triazol-1-yl)cyclohexanone	Investigative	50941838	C15H17N3O	255.31	CC1=CC=C(C=C1)C2=CN(N=N2)C3CCCCC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BUZ06A	5-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorobenzonitrile	Investigative	24905236	C15H13FN6	296.3	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC(=C(C=C3)F)C#N)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BUZ08E	Dithiobis(1H-indole-3-carboxamide) deriv. 10v	Investigative	5328613	C34H30N4O2S2	590.8	CC1=C2C(=CC=C1)C(=C(N2C)SSC3=C(C4=CC=CC(=C4N3C)C)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BV0EL8	Indolin-2-one deriv. 9f	Investigative	5329168	C26H24N2O3	412.5	C1CCC2=C(C1)C(=C(N2)/C=C\\3/C4=C(C=C(C=C4)C5=CC=CC=C5)NC3=O)CCC(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BV12EC	(3,4-Dimethoxy-phenyl)-(6,7-dimethoxy-quinolin-4-yl)-amine	Investigative	44330975	C19H20N2O4	340.4	COC1=C(C=C(C=C1)NC2=C3C=C(C(=CC3=NC=C2)OC)OC)OC	IC50 = 80500 nM	Poor binder
T59328	Epidermal growth factor receptor	BV3L0I	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(pyrrolidin-1-yl)pyrimidin-4-amine	Investigative	53317172	C21H20ClFN4O	398.9	C1CCN(C1)C2=NC=NC(=C2)NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BV3MG9	2-[(6-Chloro-1H-benzimidazol-2-yl)methyl]-5-phenyl-1,3,4-oxadiazole	Investigative	137634412	C16H11ClN4O	310.74	C1=CC=C(C=C1)C2=NN=C(O2)CC3=NC4=C(N3)C=C(C=C4)Cl	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BV3YL9	(Z)-3-(2,4-Dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid	Investigative	5329150	C24H22N2O3	386.4	CC1=C(NC(=C1CCC(=O)O)C)/C=C\\2/C3=C(C=C(C=C3)C4=CC=CC=C4)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BV4G7W	N-[5-Methyl-1-[(1R,2S)-2-(prop-2-enoylamino)cyclohexyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72700008	C25H25F3N4O2	470.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)[C@@H]4CCCC[C@@H]4NC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BV4TD7	4,5-Bis(4-fluoroanilino)phthalic acid dimethyl ester	Investigative	10476762	C22H18F2N2O4	412.4	COC(=O)C1=CC(=C(C=C1C(=O)OC)NC2=CC=C(C=C2)F)NC3=CC=C(C=C3)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BV5N2G	5-[2-(2-Methoxyphenyl)-3-methylbut-1-enyl]furo[2,3-d]pyrimidine-2,4-diamine	Investigative	52942956	C18H20N4O2	324.4	CC(C)C(=CC1=COC2=NC(=NC(=C12)N)N)C3=CC=CC=C3OC	IC50 = 111400 nM	Poor binder
T59328	Epidermal growth factor receptor	BV95PD	(3Z)-3-[(3-Ethyl-4,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one	Investigative	10635478	C17H18N2O	266.34	CCC1=C(NC(=C1C)C)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BVE6N1	1 H-Indole-3-alkanamide deriv. 10g	Investigative	5328575	C24H26N4O4S2	498.6	CONC(=O)CCC1=C(NC2=CC=CC=C21)SSC3=C(C4=CC=CC=C4N3)CCC(=O)NOC	IC50 = 68000 nM	Poor binder
T59328	Epidermal growth factor receptor	BVI83H	4-(6,7-Dimethoxyquinazolin-4-yl)-N-thiophen-3-ylpiperazine-1-carboxamide;hydrochloride	Investigative	45262293	C19H22ClN5O3S	435.9	COC1=C(C=C2C(=C1)C(=NC=N2)N3CCN(CC3)C(=O)NC4=CSC=C4)OC.Cl	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BVI90B	Chembl4276946	Investigative	134611886	C12H11Cl2N3O	284.14	CC1=NN(C(=C1C2=CC(=C(C=C2)Cl)Cl)N)C(=O)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BVM69H	5-Chloro-1-methyl-N-phenyl-2-sulfanylidene-3H-indole-3-carboxamide	Investigative	5328619	C16H13ClN2OS	316.8	CN1C2=C(C=C(C=C2)Cl)C(C1=S)C(=O)NC3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BVP5B8	[4-[(E)-2-Nitroethenyl]phenyl] 4-[[(2R)-1-[[(2R)-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylamino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]benzenesulfonate	Investigative	44315117	C28H35N5O10S	633.7	C[C@H](C(=O)N[C@H](C)C(=O)NCCNC(=O)OC(C)(C)C)NC(=O)C1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)/C=C/[N+](=O)[O-]	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BVU03O	4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinazoline	Investigative	44330976	C18H18N2O5	342.3	COC1=C(C=C(C=C1)OC2=NC=NC3=CC(=C(C=C32)OC)OC)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BW0J7N	5-(2,5-Dimethoxy-benzylamino)-2-hydroxy-benzoic acid	Investigative	10470221	C16H17NO5	303.31	COC1=CC(=C(C=C1)OC)CNC2=CC(=C(C=C2)O)C(=O)O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BW39NS	N-[4-(3-Bromoanilino)-3-cyanoquinolin-6-yl]-4-(propylamino)but-2-ynamide	Investigative	69956412	C23H20BrN5O	462.3	CCCNCC#CC(=O)NC1=CC2=C(C(=CN=C2C=C1)C#N)NC3=CC(=CC=C3)Br	IC50 = 130016.96 nM	Poor binder
T59328	Epidermal growth factor receptor	BW3AR5	4-(6,7-Dimethoxy-4-quinazolinyl)-N-(3,4-methylenedioxybenzyl)-1-piperazinethiocarboxamide	Investigative	9890746	C23H25N5O4S	467.5	COC1=C(C=C2C(=C1)C(=NC=N2)N3CCN(CC3)C(=S)NCC4=CC5=C(C=C4)OCO5)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWKT96	Methyl 4-(1-methyl-2-sulfanylidene-3H-indol-3-yl)butanoate	Investigative	5328546	C14H17NO2S	263.36	CN1C2=CC=CC=C2C(C1=S)CCCC(=O)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWM1Y9	3',8-Diamino-6-methoxyflavone	Investigative	10333957	C16H14N2O3	282.29	COC1=CC2=C(C(=C1)N)OC(=CC2=O)C3=CC(=CC=C3)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWN51Z	5-(4-Amino-1-((R)-1-aminopropan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenol	Investigative	24905321	C14H15FN6O	302.31	C[C@H](CN)N1C2=NC=NC(=C2C(=N1)C3=CC(=C(C=C3)F)O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWNA01	2-(6-Amino-9H-purin-9-yl)-1-(pyridin-2-yl)ethanone	Investigative	42604009	C12H10N6O	254.25	C1=CC=NC(=C1)C(=O)CN2C=NC3=C(N=CN=C32)N	IC50 = 89000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWR1Q2	N-[5-Methyl-1-(1-prop-2-enoylpiperidin-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72703789	C24H23F3N4O2	456.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4CCCN(C4)C(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWR50I	4-Fluoro-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	11338122	C22H16FN5O	385.4	C1=CC(=CC(=C1)NC(=O)C2=CC=C(C=C2)F)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWR53K	N-(2-Chloro-4-fluorophenyl)-8,9-dimethoxy-5,6-dihydropyrimido[4,5-b][1,4]benzoxazepin-4-amine	Investigative	44416508	C19H16ClFN4O3	402.8	COC1=C(C=C2C(=C1)CNC3=C(N=CN=C3O2)NC4=C(C=C(C=C4)F)Cl)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWX4G6	(3-Chloro-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine	Investigative	11737638	C15H11ClN4	282.73	C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWY97J	Dithiobis(1H-indole-3-alkanoic acid) deriv. 21	Investigative	5328551	C22H20N2O4S2	440.5	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)CC(=O)O)CC(=O)O	IC50 = 53000 nM	Poor binder
T59328	Epidermal growth factor receptor	BWZ04D	Tert-butyl N-[(2R)-1-oxo-1-[[4-[3-(trifluoromethyl)anilino]quinazolin-6-yl]amino]propan-2-yl]carbamate	Investigative	137658479	C23H24F3N5O3	475.5	C[C@H](C(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC=CC(=C3)C(F)(F)F)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BX05FD	(3Z)-3-[(5-Bromo-4,5,6,7-tetrahydro-1H-indol-2-yl)methylidene]-1H-indol-2-one	Investigative	44450546	C17H15BrN2O	343.2	C1CC2=C(CC1Br)C=C(N2)/C=C\\3/C4=CC=CC=C4NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BX1KF8	5,21-Dihydroxy-13-(propylamino)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione	Investigative	44273600	C29H28N4O9	576.6	CCCNN1C(=O)C2=C3C4=C(C(=CC=C4)O)NC3=C5C(=C2C1=O)C6=C(N5C7C(C(C(C(O7)CO)O)O)O)C(=CC=C6)O	IC50 = 59000 nM	Poor binder
T59328	Epidermal growth factor receptor	BXQ6V5	Chembl4284413	Investigative	45370166	C19H15N3O2S	349.4	C1C2=CC=CC=C2C(=O)N1C(C3=CC=CC=C3)C(=O)NC4=NC=CS4	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BXS19U	(3-Hydroxybenzylidene)propanedinitrile	Investigative	252473	C10H6N2O	170.17	C1=CC(=CC(=C1)O)C=C(C#N)C#N	Ki = 123000 nM	Poor binder
T59328	Epidermal growth factor receptor	BXSQ13	1-Methyl-2-[[1-methyl-3-(pyridin-4-ylcarbamoyl)indol-2-yl]disulfanyl]-N-pyridin-4-ylindole-3-carboxamide	Investigative	10053638	C30H24N6O2S2	564.7	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CC=NC=C5)C(=O)NC6=CC=NC=C6	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BXT54C	(3Z)-3-[(4-Ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one	Investigative	10587839	C17H18N2O	266.34	CCC1=C(NC(=C1C)/C=C\\2/C3=CC=CC=C3NC2=O)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BXW73J	5-(4-Amino-1-((4-phenyloxazol-5-yl)methyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenol	Investigative	24905308	C21H15FN6O2	402.4	C1=CC=C(C=C1)C2=C(OC=N2)CN3C4=NC=NC(=C4C(=N3)C5=CC(=C(C=C5)F)O)N	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BXYI35	N-(4-Chloro-phenyl)-6-methoxy-N'-(2-morpholin-4-yl-ethyl)-[1,3,5]triazine-2,4-diamine	Investigative	1035343	C16H21ClN6O2	364.8	COC1=NC(=NC(=N1)NC2=CC=C(C=C2)Cl)NCCN3CCOCC3	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BXZ6Q3	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(4-ethyl-phenyl)-amine	Investigative	13492273	C16H18N4	266.34	CCC1=CC=C(C=C1)NC2=NC=NC3=C2C(=C(N3)C)C	IC50 = 77500 nM	Poor binder
T59328	Epidermal growth factor receptor	BY04XF	3-(3-Bromo-5-tert-butyl-4-methoxy-benzylidene)-5-chloro-1,3-dihydro-indol-2-one	Investigative	44321395	C20H19BrClNO2	420.7	CC(C)(C)C1=C(C(=CC(=C1)/C=C\\2/C3=C(C=CC(=C3)Cl)NC2=O)Br)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY09TX	US9422297, Aag155-336	Investigative	129625873	C17H13BrN4	353.2	C1C2=CC=CC=C2C3=C1C(=NC(=N3)N)NC4=CC(=CC=C4)Br	IC50 = 98800 nM	Poor binder
T59328	Epidermal growth factor receptor	BY15FG	(4-Chloro-phenyl)-(5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine	Investigative	13492276	C14H13ClN4	272.73	CC1=C(NC2=C1C(=NC=N2)NC3=CC=C(C=C3)Cl)C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY3GX8	3-Substituted indolin-2-one 9c	Investigative	5329136	C24H22N2O4	402.4	CC1=CNC(=C1CCC(=O)O)/C=C\\2/C3=C(C=C(C=C3)C4=CC(=CC=C4)OC)NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY4D7N	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-phenyl-amine	Investigative	13492269	C14H14N4	238.29	CC1=C(NC2=C1C(=NC=N2)NC3=CC=CC=C3)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY4EX8	(2-Chloro-phenyl)-(5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine	Investigative	13492275	C14H13ClN4	272.73	CC1=C(NC2=C1C(=NC=N2)NC3=CC=CC=C3Cl)C	IC50 = 75100 nM	Poor binder
T59328	Epidermal growth factor receptor	BY4VP1	N-Methyl-N-phenylquinazolin-4-amine	Investigative	5328016	C15H13N3	235.28	CN(C1=CC=CC=C1)C2=NC=NC3=CC=CC=C32	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY5IE7	2-(1H-Benzimidazol-2-ylmethyl)-5-(4-methylphenyl)-1,3,4-oxadiazole	Investigative	137644097	C17H14N4O	290.32	CC1=CC=C(C=C1)C2=NN=C(O2)CC3=NC4=CC=CC=C4N3	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY7MP5	5-(1H-Indol-3-yl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazin-2-one	Investigative	118723185	C21H19N3O4	377.4	COC1=CC(=CC(=C1OC)OC)C2=NC(=CNC2=O)C3=CNC4=CC=CC=C43	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY9BS2	8-(4-Tert-butylanilino)-1-(3-morpholin-4-ylpropyl)-[1,3]oxazolo[4,5-g]quinazolin-2-one	Investigative	70690773	C26H31N5O3	461.6	CC(C)(C)C1=CC=C(C=C1)NC2=NC=NC3=CC4=C(C=C32)N(C(=O)O4)CCCN5CCOCC5	IC50 = 79000 nM	Poor binder
T59328	Epidermal growth factor receptor	BY9HA4	(4E)-1-(3,4-Dimethylphenyl)-4-[[5-(2-hydroxy-5-nitrophenyl)furan-2-yl]methylidene]pyrazolidine-3,5-dione	Investigative	1742852	C22H17N3O6	419.4	CC1=C(C=C(C=C1)N2C(=O)/C(=C/C3=CC=C(O3)C4=C(C=CC(=C4)[N+](=O)[O-])O)/C(=O)N2)C	IC50 = 74300 nM	Poor binder
T59328	Epidermal growth factor receptor	BY9UK4	Cc1ccc2n(C3CCCN(CC3)C(=O)C=C)c(NC(=O)c3cccc(c3)C(F)(F)F)nc2c1	Investigative	118223716	C25H25F3N4O2	470.5	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4CCCN(CC4)C(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BYA1G0	10-Hydroxy-18-N-2-naphthyl-N-phenylaminobetaenone	Investigative	10674806	C37H45NO5	583.8	CCC(C)[C@@H]1[C@@]([C@H]2[C@@H](C[C@@](C[C@@]2(C(=O)[C@@]1(C)O)O)(C)O)C)(C)C(=O)/C=C/N(C3=CC=CC=C3)C4=CC5=CC=CC=C5C=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BYG96Q	(E)-2-Cyano-3-(3,4-dihydroxyphenyl)-2-propenoic acid	Investigative	5328793	C10H7NO4	205.17	C1=CC(=C(C=C1/C=C(\\C#N)/C(=O)O)O)O	Ki = 70000 nM	Poor binder
T59328	Epidermal growth factor receptor	BYN2C8	Indolin-2-one deriv. 4d	Investigative	5329157	C18H16N2O3	308.3	C1CCC2=C(C1)C=C(N2)/C=C\\3/C4=C(C=CC(=C4)C(=O)O)NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BYO4E9	Tyrphostin deriv. 21	Investigative	5328758	C12H7N3O3	241.2	COC1=C(C=C2C(=C1)C(=C(C#N)C#N)C(=O)N2)O	IC50 = 60000 nM	Poor binder
T59328	Epidermal growth factor receptor	BYO4R3	4',8-Diamino-6-hydroxyflavone	Investigative	11777791	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=CC(=C3)O)N)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BYP78G	Flavopiridol analogue 18	Investigative	5329715	C21H20ClNO6	417.8	CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)OC4=CC=CC=C4Cl)O)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BYS1Q2	N-[(2R,3S,4S,6S)-17-Benzyl-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide	Investigative	10484487	C42H36N4O4	660.8	C[C@]12[C@H]([C@H](C[C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CN(C6=O)CC9=CC=CC=C9)N(C)C(=O)C1=CC=CC=C1)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ3XC6	Cc1ccc2n(C3CCN(C3)C(=O)C=C)c(NC(=O)c3cccc(c3)C(F)(F)F)nc2c1	Investigative	118223723	C23H21F3N4O2	442.4	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)C4CCN(C4)C(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ42NQ	N-[5-Methyl-1-[2-(prop-2-enoylamino)ethyl]benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	72700007	C21H19F3N4O2	416.4	CC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC(=CC=C3)C(F)(F)F)CCNC(=O)C=C	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ6A0U	2-[5-(2,2-Dicyanoethenyl)-2-hydroxy-3-methoxyphenyl]sulfanylacetic acid	Investigative	44361710	C13H10N2O4S	290.3	COC1=C(C(=CC(=C1)C=C(C#N)C#N)SCC(=O)O)O	IC50 = 53703.18 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ7LA9	7-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2-(diethylamino)ethyl)-1H-pyrrolo[2,3-d]pyridazine-2-carboxamide	Investigative	46879473	C26H28ClFN6O2	511	CCN(CC)CCNC(=O)C1=CC2=CN=NC(=C2N1)NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl	IC50 = 77220 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ8RV2	4-(3,4-Dimethoxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile	Investigative	5328843	C20H19N3O4	365.4	COC1=C(C=C(C=C1)NC2=C(C=NC3=CC(=C(C=C32)OC)OC)C#N)OC	IC50 = 50118.72 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ8W7J	1 H-Indole-3-alkanamide deriv. 10u	Investigative	5328588	C38H38N4O2S2	646.9	C1=CC=C(C=C1)CNC(=O)CCCC2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)CCCC(=O)NCC6=CC=CC=C6	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ8WM4	4-Methyl-5-[2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-1H-pyrrole-3-carboxylic acid ethyl ester	Investigative	10613858	C17H16N2O3	296.32	CCOC(=O)C1=CNC(=C1C)/C=C\\2/C3=CC=CC=C3NC2=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZ9R1T	2-[(4-Hydroxy-3-methoxyphenyl)methylidene]propanedinitrile	Investigative	19424	C11H8N2O2	200.19	COC1=C(C=CC(=C1)C=C(C#N)C#N)O	Ki = 67000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZA0L9	2-(3,4-Dihydroxyphenyl)benzothiazole-4,6-diol	Investigative	135407125	C13H9NO4S	275.28	C1=CC(=C(C=C1C2=NC3=C(C=C(C=C3S2)O)O)O)O	IC50 = 130000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZG3L0	N-[4-(4-Sulfamoylanilino)quinazolin-6-yl]prop-2-enamide	Investigative	76332996	C17H15N5O3S	369.4	C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC=C(C=C3)S(=O)(=O)N	IC50 = 76500 nM	Poor binder
T59328	Epidermal growth factor receptor	BZJ70U	4-[[4-Amino-6-cyano-2-(2-hydroxyethylamino)-5-methylpyrido[2,3-d]pyrimidin-7-yl]amino]benzenesulfonamide	Investigative	57392008	C17H18N8O3S	414.4	CC1=C(C(=NC2=NC(=NC(=C12)N)NCCO)NC3=CC=C(C=C3)S(=O)(=O)N)C#N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZNF82	2-Methoxy-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10136330	C24H21N5O2	411.5	CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2OC)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZO9L8	2-(1H-Benzimidazol-2-ylmethyl)-5-thiophen-2-yl-1,3,4-oxadiazole	Investigative	137650197	C14H10N4OS	282.32	C1=CC=C2C(=C1)NC(=N2)CC3=NN=C(O3)C4=CC=CS4	IC50 = 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZOT67	4',5,7-Triamino-6-hydroxyflavone	Investigative	157820	C15H13N3O3	283.28	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3N)O)N)N	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZPC85	Tyrphostin AG 126	Investigative	2046	C10H5N3O3	215.16	C1=CC(=C(C=C1C=C(C#N)C#N)O)[N+](=O)[O-]	Ki = 150000 nM	Poor binder
T59328	Epidermal growth factor receptor	BZVU43	N-[1-(4-Hydroxycyclohexyl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide	Investigative	134143736	C21H20F3N3O2	403.4	C1CC(CCC1N2C3=CC=CC=C3N=C2NC(=O)C4=CC(=CC=C4)C(F)(F)F)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D00ATA	(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one	Investigative	5908088	C13H10N2O	210.23	C1=CC=C2C(=C1)/C(=C/C3=CC=CN3)/C(=O)N2	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D00GVV	Indolin-2-one deriv. 4b	Investigative	5329155	C17H15BrN2O	343.2	C1CCC2=C(C1)C=C(N2)/C=C\\3/C4=C(C=CC(=C4)Br)NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D04NGS	JNJ-7706621	Investigative	5330790	C15H12F2N6O3S	394.4	C1=CC(=C(C(=C1)F)C(=O)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D04PEI	BMS-509744	Investigative	11467730	C32H41N5O4S2	623.8	CC1=CC(=C(C=C1SC2=CN=C(S2)NC(=O)C3=CC=C(C=C3)CNC(C)C(C)(C)C)C(=O)N4CCN(CC4)C(=O)C)OC	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D07OSK	VEGF receptor 2 kinase inhibitor I	Investigative	6419834	C18H18N2O3	310.3	CCOC(=O)C1=C(NC(=C1C)/C=C\\2/C3=CC=CC=C3NC2=O)C	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0D6DH	A-432411	Investigative	10125830	C20H16N2O3	332.4	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=CC=CN4)/C(=O)N3)O	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0HE0E	SU4984	Investigative	5941540	C20H19N3O2	333.4	C1CN(CCN1C=O)C2=CC=C(C=C2)/C=C\\3/C4=CC=CC=C4NC3=O	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0L8HO	RO-316233	Investigative	2399	C20H13N3O2	327.3	C1=CC=C2C(=C1)C(=CN2)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54	IC50 ~ 50000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0YE1X	4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Investigative	9927943	C19H19NO5	341.4	COC1=C(C=C(C=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC)OC	IC50 ~ 100000 nM	Poor binder
T59328	Epidermal growth factor receptor	D0YZ7H	JNJ-10198409	Investigative	9797370	C18H16FN3O2	325.3	COC1=C(C=C2C(=C1)CC3=C2NN=C3NC4=CC(=CC=C4)F)OC	IC50 ~ 100000 nM	Poor binder